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Abstract
With the advent of high-throughput and genome-wide screening initiatives, there is a need for
improved methods for cell-based assays. Current approaches require expensive equipment,
rely on large-scale culturing formats not suited for small or rare sample types, or involve
tedious manual handling. Microﬂuidic systems could provide a solution to these limitations,
since these assays are accessible, miniaturized, and automated. When coupled with high-
content analysis, microﬂuidics has the potential to drastically increase throughput in cell
biology and drug discovery. In light of these beneﬁts, we developed 3 microﬂuidic approaches
for mammalian cell-based assays: (1) printing of live mammalian cells into nanowell arrays, (2)
a high-throughput transfection device, and (3) a module that generates complex, continuous
concentration proﬁles.
Our ﬁrst technique generates high-density nanowell arrays of live mammalian cells (LMCAs)
using a standard contact microarrayer. Both commonly used cell lines and primary cells
cultured on the arrays are highly viable and maintain their signature phenotype, making the
platform suitable for long-term stem cell differentiation studies. Our 675-well array is ~2.6x
more dense than a 1,536-well microtiter plate and can be frozen and thawed, facilitating the
handling, storage, and screening of large libraries of cells.
LMCAs are also compatible with transfection, a technique that could enable analysis of the
entire proteome in the natural cellular context. Transfection is routinely conducted on high-
throughput arrays, but this setup requires manual cell culturing and precludes precise control
over the cell environment. To this end, we created a microﬂuidic chip that streamlines cell
loading and culturing and implements 280 independent transfections at up to 99% efﬁciency.
The chip can perform co-transfections, in which the number of cells expressing each protein
and the average protein expression level can be precisely tuned as a function of input DNA
concentration. This platform is well-suited for optimizing synthetic gene circuits; we co-
transfected four plasmids to test a histidine kinase signaling pathway and mapped the dose
dependence of this network on the level of one of its constituents. The chip is readily integrated
with high-content imaging, enabling the evaluation of cellular behavior and protein expression
dynamics over time.
To complement the biological assays that could be performed on our transfection chip, we
lastly generated an accurate and automated method to manipulate molecular concentrations
on chip. Our pulse-width modulation (PWM)-based microﬂuidic module combines up to 6
different inputs and produces arbitrary concentrations with a dynamic range of 3-5 decades.
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Abstract
We created complex concentration proﬁles of 2 molecules, with each concentration indepen-
dently controllable. The PWM module can execute rapid concentration changes as well as
long-timescale pharmacokinetic proﬁles under a variety of operating conditions, making it
ideal for integration with existing devices for advanced cell and pharmacokinetic studies.
Taken together, the 3 microtechnologies developed in this work integrate and automate
mammalian cell handling, culturing, transfection, imaging, and solution preparation. These
features have far-reaching implications in ﬁelds such as synthetic biology, stem cell research,
and drug development.
Key words: microﬂuidics, microarrays, live cell printing, high-throughput screening, high-
content imaging, automated microscopy, transfection, mammalian synthetic biology, stem
cells, concentration-time proﬁles, pulse-width modulation
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Résumé
Avec l’avènement des initiatives de criblage à haut débit et du génome entier, il devient né-
cessaire de développer des nouvelles méthodes pour les essais cellulaires. Les approches
actuelles exigent des équipements coûteux, comptent sur des plate-formes de culture cellu-
laire à grande échelle qui ne sont pas compatibles avec des échantillons rares ou petits, ou
nécessitant une manipulation manuelle. Les systèmes microﬂuidiques pourraient fournir une
solution à ces limitations, puisque ces essais sont accessibles, miniaturisés, et automatiques.
Une fois couplé avec le criblage à haut contenu, la microﬂuidique a le potentiel d’augmenter
drastiquement les capacités de la biologie cellulaire et la découverte des médicaments. En
considérant ces avantages, nous avons développé 3 approches microﬂuidiques pour les essais
des cellules mammifères : (1) l’impression des cellules mammifères vivantes dans une puce à
nano-puits, (2) un dispositif pour la transfection à haut débit, et (3) un module qui génère des
proﬁls de concentration complexes et continus.
La première technique utilise un robot spotteur standard pour générer des puces denses en
cellules mammifères vivantes (LMCAs). Les espèces de cellules couramment utilisées et aussi
les cellules primaires cultivées sur les puces sont très viables et maintiennent leurs signatures
phénotypiques. Notre puce à 675 nano-puits est ~2.6 fois plus dense qu’une plaque à 1,536
micropuits et puisse être congelée et décongelée, ce qui facilite la manipulation, le stockage,
et le criblage des grandes bibliothèques des cellules.
Les LMCAs sont également compatibles avec la transfection, une technique qui permet l’ana-
lyse du protéome entier dans le contexte naturel de la cellule. La transfection est typiquement
effectuée sur des puces à haut débit, mais ce système nécessite la culture manuelle des cellules
et empêche la gestion précise de l’environnement cellulaire. Par conséquent, nous avons créé
une puce microﬂuidique qui simpliﬁe les processus de chargement, de culture des cellules, et
réalise 280 transfections indépendantes, jusqu’à une efﬁcacité de 99%. La puce est capable
d’accomplir des co-transfections, où le nombre de cellules qui exprime une protéine et le
niveau d’expression de chaque protéine puissent être réglés en changeant les concentrations
initiales de l’ADN. Cette puce est bien adapté pour optimiser les circuits génétiques synthé-
tiques; nous avons co-transfecté 4 plasmides pour examiner un système de transduction
histidine-kinase et ensuite étudié la dépendance de ce réseau sur la quantité d’un de ses
constituants. La puce est facilement intégré avec l’imagerie haut contenu, permettant l’éva-
luation temporelle du comportement des cellules et de la dynamique de l’expression des
protéines.
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Résumé
Pour compléter les essais biologiques qui pourraient être effectués sur notre puce de transfec-
tion, nous avons généré une méthode précise et automatique pour manipuler les concentra-
tions moléculaires. Notre module microﬂuidique est basé sur le concept de la modulation de
largeur d’impulsion (MLI) et combine jusqu’à 6 solutions pour produire des concentrations ar-
bitraires avec une plage dynamique de 3 à 5 ordres de grandeur. Nous avons réalisé des proﬁls
de concentration complexes de 2 molécules en parallèle, avec la capacité de contrôler chaque
molécule indépendamment. Le module MLI peut exécuter des changements de concentration
rapides et aussi des proﬁls pharmacocinétiques à long terme sous des conditions diverses.
Il est donc idéal pour l’intégration avec des dispositifs existants pour des essais cellulaires
avancés et des études pharmacocinétiques.
Prises ensemble, les trois micro-technologies présentées dans cette thèse intègrent et auto-
matisent la manipulation et la culture des cellules mammifères, la transfection, l’imagerie,
et la préparation des solutions. Ceci ouvre donc de vastes opportunités dans les domaines
de la biologie synthétique, la recherche sur les cellules souches, et le développement des
médicaments.
Mots-clés : Microﬂuidique, puces à cellules et ADN, impression des cellules vivantes, criblage
à haut débit, imagerie à haut contenu, microscopie automatisée, transfection, biologie synthé-
tique mammifère, cellules souches, proﬁls temporels de concentration, modulation de largeur
d’impulsion
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1 Introduction
1.1 High-content analysis of large cell libraries
Molecular cloning technologies for mammalian cells are well-established and constantly
improving, resulting in large collections of cell lines. These libraries are perfectly suited for
high-content screening (HCS), in which the detailed spatiotemporal information obtained
from cellular imaging is combined with the high throughput of automated cell handling
techniques1. For example, existing stably transfected cell lines and GFP-fusion libraries2 can
be cultured in the presence of therapeutic molecules of interest, yielding insights to drug
mechanisms and cell escape from drug action. Monitoring the quantity and localization
of ﬂuorescently tagged proteins at high temporal resolution can determine the individual
contribution of thousands of proteins to the overall cell response. HCS can also be applied to
large compilations of cancer cell lines and samples3. Screens performed with a large diversity
of cells better reﬂect the heterogeneity of patient samples and primary tumors. Elucidating
the relationship between speciﬁc characteristics (e.g. genomic aberrations and transcriptional
signatures) of a sample and its response to a drug could help advance early-phase clinical
trials and personalized medicine.
Despite the abundance of information that could potentially be gathered (Fig. 1.1), we still lack
efﬁcient tools to interrogate these cell libraries. An ideal HCS method should be capable of ma-
nipulating small amounts of sample. Most primary cells are available in limited quantities, and
cancer and stem cells are susceptible to undesirable changes in phenotype or genotype when
expanded4,5. Second, cell culturing arrays should be dense, miniaturized, and modular to
ensure compatibility with high-throughput screening. Third, analysis platforms should enable
long-term and continuous monitoring at the single cell level in order to supply information
on molecular mechanisms. Finally, an ideal technique for HCS should offer advanced control
over the cell microenvironment for eventual integration with studies such as extracellular
matrix niche testing6.
One method that can be used for high-content analysis is ﬂow cytometry8,9. Flow cytometry
provides end-point measurements, preventing a detailed understanding of drug mechanisms
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Figure 1.1. Examples of cell assays that can be performed using high-content platforms,
reprinted with permission7. Copyright 2009, Annual Reviews.
and temporal responses. Moreover, cell culturing prior to ﬂow cytometry analysis is typically
performed manually and requires large sample sizes. To address this need, several automated
approaches for managing large collections of mammalian cells have been developed. One
strategy is to couple microtiter plate cell culture with robotic ﬂuidic operation. For the time
being this practice remains inaccessible to most researchers because it relies on expensive
liquid handling equipment10,11. Alternatively, inkjet printers can be used to dispense live cells
into dense arrays12–14. This technique requires each sample to be individually loaded into the
printer and cannot manage multiple samples. Contact spotting, a method widely employed to
produce DNA and protein microarrays15,16, has also been explored for the micropatterning of
cells. Previous studies have succeeded in arraying ﬁxed cells17 and gelatinous preparations
containing a single cell type18. Contact spotting is a versatile and standard technique, and
cell arrays generated in this manner could be combined with arrays of small molecules, drugs,
and proteins to execute more sophisticated experiments. Live cell arrays could be maintained
in culture and monitored over time, providing a wealth of information. Nevertheless, to date it
remains a challenge to array many types of live cells at once with contact spotting.
1.2 Transfection
Cell-based research often entails expressing and studying speciﬁc proteins. Transfection is
the process of introducing foreign genetic material into mammalian cells19. In contrast to
those produced in prokaryotic systems, the expressed proteins undergo proper folding and
post-translational modiﬁcations. This technology is thus pertinent to protein production,
functional assays, and therapeutic gene delivery. Transfection can be achieved by many bi-
ological, chemical, and physical means (summarized in Table 1.1). Chemical transfection
generally involves cationic reagents that neutralize the negative charge of DNA. For instance,
cationic lipids are commercially available and widely used, and their structure facilitates entry
into the cell by endocytosis or phagocytosis. Other reagent-based approaches include calcium
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phosphate precipitation20 and nanoparticles21. A variety of physical strategies including mag-
netic delivery22, optical transfection23, sonoporation24, electroporation25, microinjection26,
and cell squeezing27 have also been developed. One shortcoming of the techniques men-
tioned above is that genetic material is delivered to the cytoplasm and must translocate into
the nucleus to permit transcription into mRNA. These approaches work best for dividing cells;
the nuclear envelope breaks down during mitosis, allowing foreign genetic material to enter28.
Viral-mediated methods (called transduction), in contrast, can introduce large quantities of
genetic material into a wide range of non-dividing cells29,30. This strategy takes advantage of
the infection and gene delivery capabilities of retroviruses, lentiviruses, adenoviruses, and
adeno-associated viruses. The viral vectors are modiﬁed to be replication-deﬁcient for safety
reasons31. Retroviruses and lentiviruses are able to integrate into the genome, providing stable
protein production. Despite their high efﬁciency of transduction, viral vector production
requires several days to weeks, concentration by ultracentrifugation, and a BSL2 laboratory32.
1.3 Reverse transfection
Integration with contact spotting has adapted transfection for high-throughput screening. In
this technique, called reverse transfection, puriﬁed cDNA samples are mixed with chemical
transfection reagent and spotted onto glass slides33 (Fig. 1.2). siRNA can also be arrayed for
loss-of-function studies. The arrays are next seeded with cells, which undergo transfection in
situ and convert the cDNA into protein. Unlike protein microarrays16,34,35, this method does
not require individual puriﬁcation of each protein and proteins can be analyzed in the natural
cellular context. More than 5,000 samples can be printed on a single glass microscope slide
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Table 1.1. Comparison of transfection methods, adapted from Kim et al.19
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Figure 1.2. The reverse transfection technique, reprinted with permission7. Copyright 2009,
Annual Reviews.
using standard techniques33,36, and a recent study was able to further increase this density37.
This throughput would allow for the screening of genome-wide RNAi and cDNA libraries38,39.
With the accumulation of data from cDNA microarrays and whole genome sequencing, there
is a need to validate protein function and characterize therapeutic targets.
1.4 Mammalian synthetic biology
Aside from its utility in proteomic studies, reverse transfection could serve as a valuable tool
for mammalian synthetic biology. Synthetic biology is a “bottom-up” approach to engineering
synthetic gene networks and is relevant to applications such as biosensors, sustainable energy
sources, and biomedical therapies40. Prokaryotes are often used for synthetic biology because
they are receptive to genetic modiﬁcations, but the clinical applications of these models
are limited. Engineering mammalian systems remains more difﬁcult due to their advanced
mechanisms to evade foreign genetic material, extensive compartmentalization, and tight
gene regulation41. Nevertheless, mammalian synthetic biology could signiﬁcantly beneﬁt
biotechnology, for instance in protein production and providing novel therapies through stem
cell engineering40,42.
These potential beneﬁts emphasize the need to develop new approaches for studying mam-
malian synthetic systems. Successful implementation of these systems requires multiple
genetic constructs to be simultaneously delivered to cells at precise ratios, necessitating
painstaking optimization of the transfection conditions43,44. Typical experiments involve
multiwell plates, meaning that cell culturing and transfection mixtures must be prepared
by hand. Reverse transfection could accelerate the testing of synthetic networks because
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transfection mixture arraying and cell seeding is highly automated and streamlined. Addition-
ally, the high-content imaging that accompanies reverse transfection presents an attractive
alternative to the ﬂow cytometry analysis that conventionally follows multiwell plate culture.
Continuous imaging of an array of circuit-expressing cells would supply temporal data, which
is especially important for oscillating systems45. However, to date, reverse transfection has
not been applied in the context of synthetic biology.
1.5 Microﬂuidic devices for mammalian cells
Although reverse transfection has been optimized for a variety of genetic materials46,47 and
cell types48, methods for cell manipulation on the arrays still stand to be improved. Cell
seeding and culturing is performed manually, and spots on the live cell array are not physically
separated from one another. This setup offers poor control over the cell microenvironment,
preventing more sophisticated downstream experiments from being executed on the array.
Cross-contamination on the array is a prominent concern, and efforts have been made to
separate DNA spots with silicon gaskets49 and cell-repellent coatings50.
Microﬂuidic devices present a possible solution to the shortcomings of reverse transfection
arrays described above. By enclosing each position on the array in a cell culturing chamber,
one could implement long-term experiments and studies with poorly adherent or highly
migrant cell types. Despite these advantages, progress in combining transfected cell arrays
with microﬂuidics has been slow. Biochip platforms have obtained between 13 and 80% trans-
fection efﬁciency51–53, with throughputs ranging from 1 to 96 reactions per device54–57. These
systems do not incorporate mechanisms for medium replenishment in the cell chambers,
prohibiting long-term experiments or ﬂow manipulation. In contrast, standard cell culturing
chips are capable of variety of functions, including long-term perfusion culture and the ability
to individually address cell chambers58 (Fig. 1.3). This discrepancy highlights the need for an
improved microﬂuidic transfection platform.
Modern microﬂuidic devices like the one presented in Figure 1.3 contain micromechanical
components such as valves, mixers, and pumps that allow them to carry out complex chemical
and in vitro biological assays59. Microﬂuidic large-scale integration has facilitated massively
parallel experiments, in which reactions can be addressed individually on the chip60. In
addition to high throughput, microﬂuidic devices are characterized by automation, small
sample requirements, and compatibility with other analytical techniques. The micrometer
dimensions of these chips equate to a laminar ﬂow regime. The absence of turbulence permits
ﬂowing several ﬂuids in parallel, and this feature enables novel diffusion-based experiments.
Moreover, the dimensions of average microﬂuidic elements (10-100 μm) are perfectly compati-
ble with the diameter of eukaryotic cells, making it possible to achieve complex manipulations
on the single cell level. The cell environment on chip can be customized by incorporating
microfabricated structures61 or using contact spotting, a microﬂuidic-compatible technique,
to deposit ECM molecules and growth factors6,62. For the reasons mentioned above, mi-
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Figure 1.3. A microﬂuidic cell culture system, reprinted with permission58. Copyright 2007,
American Chemical Society.
croﬂuidics is positioned to revolutionize the way mammalian cell studies are performed.
Mammalian microﬂuidic chips have already been designed for a large variety of purposes,
including drug screening63,64, genome analysis65, single-cell analysis66, and stem cell stud-
ies67,68. Chips with new applications are constantly being developed, imparting us with a
better understanding of cellular processes and guiding the development of new therapies.
1.6 Complex, continuous concentrationproﬁles onmicroﬂuidic de-
vices
In the wake of the aforementioned developments in microﬂuidic technology, an increasing
number of laboratories is turning to on-chip platforms to implement cell-based assays. Mi-
croﬂuidic devices used for these purposes are connected to a small number of input solutions,
and a typical experiment ﬂows one solution through the chip at a time. To introduce a dif-
ferent concentration or a new molecule on the chip a new input solution is used, incurring
frequent step function changes. This setup poorly reﬂects the concentration changes that
occur in vivo. For example, the quantity of a drug in blood plasma ﬂuctuates over many hours,
following a complex, continuous rise and fall pattern. The ability to create complex temporal
concentration proﬁles of one or more substances would enable the accurate study of changing
antibiotic concentrations on bacteria, the effect of drugs on mammalian cells, and stem cell
differentiation.
Simple concentration proﬁles have been previously created on chip by means of lateral
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Figure 1.4. Examples of diffusion gradient-based concentration proﬁles on microﬂuidic chips.
Reprinted with permission69. Copyright 2009, Royal Society of Chemistry.
diffusion-based gradients70,71. Two ﬂuids are simultaneously ﬂowed parallel to one another
along the length of a channel or chamber, establishing a gradient that is perpendicular to the
direction of the ﬂow (Fig. 1.4). This principle has been used to design microﬂuidic devices
capable of preparing up to 81 chemical combinations69. The total possible outputs depend
on the number of inputs (16 stock solutions are needed to produce 81 different solutions) and
because this approach is diffusion-based, it offers poor spatio-temporal resolution. Several
active mixing techniques72 including mechanical micromixers73, microstructures74, inte-
grated peristaltic pumps75, and serial dilution schemes76 have been developed to provide fast
concentration changes. Nevertheless, on these devices the number of possible concentrations
produced is also limited and deﬁned by the number of solution inputs.
To generate small changes in concentration over a large range, dynamic strategies such as
pulse-width modulation (PWM) are necessary. PWM (Fig. 1.5) is an electrical engineering
concept that encodes an analog signal in a series of repeating on and off pulses of supplied
current or voltage77. The microﬂuidic equivalent switches between ﬂowing buffer and sub-
strate reservoirs. Alternating pulses of buffer and substrate are directed through a long mixing
channel, where they diffuse to homogeneity. Total cycle time (time to execute one pulse of
buffer and one pulse of substrate) is kept constant. Different concentrations are created by
varying the duty cycle, which refers to the fraction of time occupied by the substrate pulse in
comparison to the total cycle time.
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Figure 1.5. Using pulse-width modulation with different duty cycles to vary output. On = high
level, off = low level.
1.7 Pharmacokinetic/pharmacodynamic studies onmicroﬂuidicde-
vices
Long-term concentration manipulation orchestrated by PWM on microﬂuidic devices would
be interesting for pharmacokinetic and pharmacodynamic (PK/PD) studies. These assays
are central to drug discovery and development80,81. For example, monitoring the concen-
tration of a drug in plasma over time reveals information on the efﬁcacy of a drug’s delivery
method, release from pharmaceutical formulation, adsorption into circulation, distribution
into ﬂuids and tissues, and metabolism and excretion (Fig. 1.6). Measuring bacterial load
along the course of a well-characterized PK proﬁle could yield information on the mechanism
of an antibacterial drug and determine whether adjustments in factors such as drug dosage,
administration, or formulation are needed. Performing these assays in vitro would provide
predictions that could reduce both the cost and duration of clinical trials. Existing in vitro
PK/PD models generally consist of a central bacteria-containing component connected to
drug and medium reservoirs controlled by syringe pumps82. While able to properly reproduce
the pharmacokinetics of drugs in vivo, these models supply only bulk measurements. The
simpliﬁed, large setup poorly represents the complex in vivo environment and is not com-
patible with techniques that probe single cell phenotypes. Although microﬂuidic chips have
been designed to address this need83,84, these devices lack the ability to simulate the gradually
rising and falling concentrations of drugs in plasma. Ideally, a device should be able to create
8
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Figure 1.6. (a) Pharmacokinetic parameters describing a typical plasma concentration time
proﬁle after an oral administration of a drug. Cmax, maximum concentration; tmax, time to
Cmax; AUC, area under the curve; MEC, minimum effective concentration; MTC, maximum
tolerated concentration. Reprinted with permission78. Copyright 2006, Nature Publishing
Group. (b) The equation79 characterizing the time-concentration proﬁle for a single oral dose
of a drug, such as the one shown in (a). ka = absorption rate constant, k = elimination rate
constant, X = amount of drug in the body, X0 = amount of drug at the absorption site, t = time.
realistic PK/PD proﬁles for multiple substances at once. PWM-based microﬂuidic devices
could facilitate in vitro PK/PD studies, but existing PWM chips85–87 are restricted in versatility
(limited suitability for different ﬂow rates, molecule sizes, multiple molecules in parallel, etc.)
and have not been used for experiments longer than 1.5 h, limiting their utility for biological
assays.
1.8 Objectives and overview of this work
As previously described, new and improved high-content screening methods would be ben-
eﬁcial for studying large libraries of cells and rare cell types. In Chapter 2 of this work, we
present a contact spotting method to create nanowell arrays of live mammalian cells (LMCAs).
The technique uses standard laboratory equipment and is compatible with both primary cells
and commonly used cell lines. Following deposition of cells into the wells, the arrays can
be cultured for extended periods of time and monitored by microscopy. Our technique is a
simple yet powerful alternative to robotic ﬂuid manipulation and inkjet printing and can be
used for high-content analysis.
9
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Dense cell culturing setups can also be achieved using microﬂuidic devices, which are likewise
easily adapted to high-content imaging88–90. Chapter 3 describes the integration of reverse
transfection with microﬂuidics. We addressed the limitations of current platforms by engi-
neering a novel microﬂuidic device that performs high-throughput transfection, culturing,
and manipulation of cells. The microﬂuidic environment permits time-lapse studies and can
introduce ﬂuidic stimuli, for instance changes in the culturing medium or perfusion with a
drug58. We demonstrated the utility of this device by using it to characterize synthetic gene
circuits. Mammalian synthetic biology could have far-reaching clinical implications, but the
lack of suitable methods for large-scale transfection optimization and screening represents
a signiﬁcant bottleneck. Our device streamlines the processes of transfection optimization,
cell culturing, and circuit testing, increasing the throughput and accessibility of mammalian
synthetic biology.
In addition to the high-throughput protein expression platform detailed in Chapter 3, another
useful feature for microﬂuidic chips would be an accurate and automated method to manipu-
late molecular concentrations on chip. The ability to generate arbitrary and complex temporal
concentration proﬁles would enable biologically relevant experiments. In Chapter 4, we de-
scribe the development of a PWM-based microﬂuidic device that implements concentration
changes over both short and long time scales, making it capable of producing complex PK/PD
proﬁles. The module is easily integrated into existing chip designs or connected upstream
of a second chip. Our chip can function with a variety of molecule sizes and ﬂow rates, and
two substances can be manipulated in parallel. The chip supports a dynamic range of nearly
3 orders of magnitude in output concentrations. The device presented in Chapter 4, taken
together with the developments discussed in Chapters 2 and 3, highlights novel applications
of microtechnologies while maintaining the original advantages of automation, small sample
size, and high-throughput.
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2.1 Abstract
High-content assays have the potential to drastically increase throughput in cell biology and
drug discovery, but handling and culturing large libraries of cells such as primary tumor or
cancer cell lines requires expensive, dedicated robotic equipment. We developed a simple yet
powerful method that uses contact spotting to generate high-density nanowell arrays of live
mammalian cells for the culture and interrogation of cell libraries.
2.2 Introduction
Cell-based assays and the tools used to perform them are constantly undergoing improve-
ments toward higher experimental throughput, reduced reagent consumption and advanced
control of the cell microenvironment7,91. There are currently two main approaches for con-
ducting high-content cell culture experiments. In the ﬁrst, cells are cultured in microtiter
plates, and robotic equipment is used to perform all necessary ﬂuidic operations92. Although
effective, this method remains unavailable to researchers in many laboratories because of
the requirement for expensive robotics. A second approach is reverse transfection33,93,94, but
complex cell libraries cannot be investigated by this method.
As an alternative, contact spotting offers an affordable yet high-throughput platform. This
technique is extensively used to generate high-density DNA and protein arrays and has been
adapted to other purposes17. To date, contact spotting has not been used to array live mam-
malian cells because of rapid spot evaporation and consequent cell death. Therefore, arraying
of live mammalian cells has been limited to inkjet printing, which lacks the ability to handle a
large number of different samples14,18.
Large collections of mammalian cell lines have recently become available, including primary
tumor and cancer cell lines3, stably transfected expression cell lines, and GFP-fusion libraries2.
Novel approaches are required to efﬁciently assemble complex arrays of hundreds to thou-
sands of genetically diverse cells. We developed a simple, fast, and scalable method that
uses standard microarray printing tools to generate high-density nanowell arrays. A minimal
sample requirement of 500 cells enables the interrogation of cells that are available in limited
quantities or cells that cannot be expanded because of undesirable changes in phenotype or
genotype, as in the case of stem cells and cancer cell lines5.
2.3 Results
2.3.1 A robust method to array live cells
We generated live mammalian cell arrays (LMCAs) of both primary cells and commonly used
cell lines. We collected cells from standard culture formats and resuspended them in Percoll, a
high-density, cell-compatible colloidal suspension routinely used for the isolation of primary
12
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Figure 2.1. Substrate preparation and cell attachment. (a) Schematic: a perforated PDMS
membrane of approximately 400 μm thickness was cut and adhered to a microscope coverslip.
Separately, an array of 1% BSA matching the pitch of the membrane was spotted onto a
microscope slide. The membrane wells on the coverslip were manually aligned to the BSA
spots on the slide. The nanowells were ﬁlled with medium before cell spotting. Spotted arrays
were incubated for one hour in a humidiﬁed petri dish to allow for cell attachment. After
incubation, the array was covered with medium for culture. (b) Photograph of the PDMS
membrane, the coverslip, and the epoxy slide. (c) Photograph of an array inside a petri dish
during the cell attachment stage. The water in the dish quickly evaporates, saturating the
atmosphere in the petri dish and preventing evaporation from the nanowells while cells attach.
cells. Cells plated in conical 384-well plates were taken up by a microarray spotting pin and
delivered to a 48-well poly(dimethylsiloxane) (PDMS) array (~20 wells/cm2) or a 675-well
acrylic array (~36 wells/cm2) adhered to a coverslip or glass slide, respectively (Fig. 2.1). For
comparison, the density of a 1,536-well plate is 14 wells/cm2. Each nanowell has a 500-nl
capacity and was ﬁlled with medium before array spotting to ensure viability of the added
cells and to enable the automated handling of nanoliter volumes of live cells. Once arrayed,
cells were incubated in a high-humidity environment for 60 min to allow them to attach to the
glass surface (Fig. 2.1). After attachment, the array was submerged in medium for culturing
and imaging (Fig. 2.2a).
Arraying cells suspended in standard medium resulted in poor performance in terms of cell
transfer, requiring hundreds of thousands of cells per sample (Fig. 2.2b). Resuspending cells
13
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Figure 2.2. A method to array live mammalian cells. (a) Schematic of the method. (b) Quan-
tiﬁcation of cell transfer. The number of cells transferred to a nanowell (cells spotted) from
source wells containing the indicated number of cells (cells plated) with and without Percoll.
Error bars, s.d. (n = 3). (c) Micrograph of NIH-3T3 ﬁbroblasts expressing tdTomato spotted in
the top row, to assess cell carryover by the spotting pin. (d) Micrograph of an array in which
three wells were spotted with 3T3 ﬁbroblasts expressing tdTomato (ﬁrst row) and three wells
were spotted with HEK293 cells expressing GFP (third row) to assess direct cell transfer across
wells. (e) Micrograph of a 48-well array seeded in all wells with NIH-3T3 ﬁbroblasts expressing
tdTomato and imaged 2 d after spotting.
in Percoll improved the efﬁciency of transfer by several orders of magnitude. This approach
allowed spots containing ~40 cells to be reproducibly arrayed from samples of 1,000 cells
(Fig. 2.2b). The number of cells delivered to each nanowell can be tuned by the initial sample
cell density, so that ~10-400 cells can be delivered from input samples of 500-50,000 cells
(Fig. 2.2b). The number of cells transferred decreased with successive printings, but it was
nonetheless possible to print repeatedly from the same sample (Fig. 2.3).
2.3.2 Cross-contamination on the arrays
Cross-contamination between nanowells can, in principle, occur by two mechanisms: (i)
carryover of cells between spots by the pin and (ii) direct transfer of cells between nanowells
when medium is added to the nanowell array. To investigate contamination via carryover,
we alternated spotting samples of cells and, as negative controls, samples of medium, with a
14
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Figure 2.3. Quantiﬁcation of cell transfer vs. number of spots printed from the same well for
ﬁve different cell densities. The number of cells transferred decreases as multiple spots are
printed from the same well, but it is nevertheless possible to reliably print several samples
using as few as 1,000 cells. Data points are the mean s.d. (n=3).
pin-wash cycle between each sample (see methods). We found no cells in the negative control
nanowells (Fig. 2.2c). To investigate contamination during addition of medium, we spotted
an array of cells in which most wells were left empty. These originally empty wells remained
uncontaminated after the exchange of medium (Fig. 2.2d). When printing larger arrays in
which all nanowells were programmed with cells, we identiﬁed a low degree of contamination,
amounting to 2 of 48 nanowells (4%; Fig. 2.4).
2.3.3 Viability of multiple cell types after arraying
To assess the viability of cells after the arraying process, we prepared 48 separate aliquots of
NIH-3T3 ﬁbroblasts on a source plate and transferred each aliquot to a separate nanowell. We
washed the pin after spotting each sample, thus simulating the arraying of 48 different cell
samples (Fig. 2.2e). The ﬁbroblasts stably expressed a red ﬂuorescent protein that rapidly dis-
perses upon cell lysis, allowing ﬂuorescence to serve as a direct measure of cell viability. After
the cells were arrayed, they remained viable and quickly became conﬂuent in the nanowell
15
Chapter 2. Live mammalian cell arrays
Figure 2.4. Quantiﬁcation of contamination due to direct transfer of cells across wells. Collage
of micrographs of an array prepared with a checkerboard pattern of red and green ﬂuorescent
cells after one day of culture. The cells used were tomato NIH-3T3 and GFP HEK293. The
array was prepared by plating 48 wells with samples containing 5,000 cells each and spotting a
single time from each of them. We observed cells that do not correspond to the printed type in
two separate nanowells, one cell in each case (arrows).
(Fig. 2.5). We also tested the viability of cells in LMCAs after freezing them. We could freeze
and thaw both the 48-well PDMS and the 675-well acrylic LMCAs without substantial effects
on cell viability (Fig. 2.6).
The LMCA method can be applied to a variety of mammalian cell types, including NIH-3T3
ﬁbroblasts, human liver carcinoma (Hep G2), human embryonic kidney (HEK) and Chinese
hamster ovary (CHO) cells (Fig. 2.7, 2.8a). We also applied this method to primary cells. We
spotted human bone marrow-derived mesenchymal stem cells (hMSCs) and maintained them
in culture for over 2 weeks with no contamination or detectable decrease in cell viability
(Fig. 2.8a).
Figure 2.5. Micrographs of four nanowells where an increasing number of cells was printed.
The upper and bottom rows show cells after one and three days of culture, respectively. Cells
grew rapidly, indicating that they sustained no damage during the spotting process.
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Figure 2.6. Freezing of LMCAs. The cells used for the 48 well PDMS array were tomato and GFP
NIH-3T3 ﬁbroblasts (left two panels). Micrographs of the 48 well array were taken immediately
before freezing and 3.5 h after thawing the array. CHO cells were used for the 675 well array
(right two panels). Micrographs of the 675 well array were taken immediately before freezing
and 22 h after thawing the array. Cells did not signiﬁcantly detach from the array during the
freeze/thaw procedure and remained viable.
Figure 2.7. Collage of micrographs of an array featuring four different cell types separated
by rows: NIH-3T3, HepG2, CHO and HEK293. All cells are viable after one day of culture,
and those expressing a ﬂuorescent marker continue to do so. For each row in the array, three
separate input wells containing 10,000 cells each were used. Cells were printed sequentially
from left to right.
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Figure 2.8. Applications of the arraying method. (a) Brightﬁeld and ﬂuorescence images of
ﬁve cell types spotted and cultured in PDMS nanowell arrays. hMSCs were cultured for up to
14 d (insets show magniﬁcation of boxed regions); all other cell types were cultured for up to 2
d. (b) Fluorescence micrograph of an entire 675-well acrylic array in which 339 of the wells
were spotted with 3T3 ﬁbroblasts by simultaneously using three spotting pins. Boxed region
of the array is magniﬁed on the right. (c) Fluorescence (left) and brightﬁeld (right) images,
20 h after reverse transfection of CHO cells with plasmid encoding tdTomato (spotting of a
lipid-DNA mixture) in 48 nanowells of a PDMS array followed by manual addition of cells.
(d) Regular transfection of CHO cells spotted into the 675-well array, followed by spotting
of tdTomato plasmid transfection mixture into the wells. Images were acquired 45 h after
transfection.
2.3.4 High-density LMCAs
To test the scalability of this technique, we also used acrylic arrays with 675 nanowells
(Fig. 2.8b, 2.9). The 675-nanowell arrays are commercially available (ALine, Inc.), and dimen-
sions such as well size and pitch can be customized. Our array had wells of 1 mm diameter
and 1.5 mm pitch, enabling the entire substrate to ﬁt on a microscope slide. A single 4-well
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Figure 2.9. Fluorescence micrograph of an entire 675-well acrylic array in which some of the
wells were spotted with tdTomato-expressing 3T3 ﬁbroblasts by simultaneously using three
spotting pins. Boxed region of the array is magniﬁed on the right.
microtiter plate could thus be used to culture up to 2,700 cell types. We programmed 339 of
the 675 wells with cells (Fig. 2.8b). Twenty-four hours after spotting, 331 of the wells contained
viable cells, indicating a 2% failure rate in cell transfer. Forty wells that were not originally
spotted contained cells (32 contained a single cell and the rest contained two or three cells).
Therefore, 7% (48 of 675) of the nanowells were either contaminated or contained no cells
when they should have had cells.
2.3.5 Transfection on the LMCAs
LMCAs are compatible with transfection. The standard reverse transfection protocol uses
microarraying pins that generate small diameter spots (120-150 μm) that dry rapidly and
uniformly33. However, for our LMCA nanowells, spots of 1 mm diameter were required. Larger
spots tend to dry slowly and unevenly, causing the majority of the transfection reagent to
concentrate at the edges of the nanowell. Reverse transfection has been achieved using the
large wells of 24-well microtiter plates95, but the microliter volumes of reagents adminis-
tered to each well preclude the use of a microarrayer. We developed a method that uses
the microarraying pin for automated deposition of homogeneous lipid-DNA spots into the
nanowells of our PDMS arrays. Upon introducing cells into the wells with a micropipette, we
achieved 32% transfection efﬁciency, with transfected cells uniformly distributed throughout
the nanowell (Fig. 2.8c). Manually depositing larger volumes of reagent did not improve
efﬁciency (Fig. 2.10), suggesting that our spotting protocol was sufﬁcient to increase the local
concentration of the transfection reagent at the site of cell attachment. Our method addresses
two limitations of standard reverse transfection: the physical separation of cells on our array
prevents cross-contamination and also allows for the inclusion of additional soluble factors.
We also tested a regular transfection approach, spotting cells before adding lipid-DNA com-
plexes. Using the acrylic 675-well array, transfection efﬁciency was 20% for the wells with
manually added transfection reagent (Fig. 2.8d). Efﬁciency was lower for wells in which the
lipid-DNA was introduced by a microarraying pin (13%), most likely due to the limited ~20
nl transfer volume of the pin (Fig. 2.10). We achieved considerably lower efﬁciency with the
PDMS 48-well array (Fig. 2.10).
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Figure 2.10. (a) Reverse transfection, 48 well PDMS array. Lipid-DNA mixture was spotted
or manually deposited into the nanowells and dried, then CHO cells were manually added.
(Images: 20 h). Left panels: tdTomato ﬂuorescence (transfected cells), right: brightﬁeld.
When available, transfection efﬁciencies are indicated. (b) Regular transfection, 48 well PDMS
array. CHO cells were spotted into the array, followed by spotting of a 1x or 2x concentrated
transfection mixture into the wells. (Images: 42 h). Transfection efﬁciency was lower on
the PDMS array when compared to the acrylic array and was not improved by using higher
concentrations of transfection reagent. The hydrophobic PDMS may sequester the lipid
transfection reagent; in regular transfection the lipid-DNA mixture is exposed to the PDMS
when it is added to medium-ﬁlled nanowells. (c) Regular transfection, 675 well acrylic array.
CHO cells were spotted into the array and transfection mixture was spotted or manually
deposited into the wells. (Images: 45 h.)
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Figure 2.11. Human mesenchymal stem cell array. (a) DAPI and phalloidin stains of hMSCs
spotted into the 48-well PDMS array from sample wells containing 500-7,000 cells. (b) hMSC
differentiation scheme and micrographs of individual nanowells from the PDMS array. Bright-
ﬁeld (BF), DAPI and Nile Red stains are shown. On the DAPI micrographs, total cell numbers
are indicated. In the Nile Red pseudocolor scale, the highest adipogenic differentiation is
indicated by red and white pixels.
2.3.6 Primary cells on the LMCAs
We also spotted hMSCs at different densities in a controlled fashion, which resulted in a
cell-transfer efﬁciency similar to that observed with standard cell lines (Fig. 2.11a). We could
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spot ~5 cells into the nanowells when using a sample well containing as few as 500 cells, and
up to ~80 cells when using samples of 7,000 cells (Fig. 2.12).
We repeatedly used each sample well to spot 4 nanowells, which resulted in fewer cells de-
posited into each subsequent nanowell. We investigated the adipogenic differentiation poten-
tial of hMSCs cultured on arrays for up to 10 d. We spotted the hMSCs at a variety of densities
and incubated the array in proliferation medium for 2 d. Then we placed the array into differ-
entiation medium for 8 d. At the end of the 10-d period, we ﬁxed the array, stained it with DAPI
and Nile Red, and imaged it. Wells that initially contained larger numbers of cells exhibited
pronounced adipogenic differentiation, as measured by Nile Red staining (Fig. 2.11b). These
cells produced large lipid vesicles that appeared as dark spots in brightﬁeld. In contrast, wells
seeded at lower densities contained cells that differentiated to a lesser extent and produced
fewer and smaller lipid vesicles.
2.4 Conclusion
In summary, we generated high-density LMCAs with a variety of mammalian cell types using
contact spotting. This method requires only a standard contact microarrayer and a nanowell
array that can be easily fabricated96 or commercially acquired (ALine, Inc.). The cell arrays
could also be used in conjunction with arrays of hydrogels and biomolecules or for screening
of artiﬁcial extracellular matrix6,97. The high-throughput approach to cell handling will enable
the parallel culture and analysis of large libraries of mammalian cells.
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Figure 2.12. (a) Quantitation of the MSC array shown in (b). The number of hMSCs spotted
into the array can be tuned by adjusting the number of cells in the well plate sample. Two
separate well plate preparations were tested for each cell concentration (circles, with the mean
value represented by the bar). hMSCs were spotted into the 48 well array at increasing densities
from left to right. The number of cells in each sample well ranges from 500 to 7,000. Each
sample in the well plate was used to spot 4 nanowells (one column), resulting in decreased
cell density from the top to the bottom of each column. Only the top row of the spotted array
was used for quantitation. (b) The hMSC cell array. Phalloidin staining was used to visualize
cell shape.
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2.5 Methods
2.5.1 Substrate fabrication
PDMS membranes were molded from SU8 structures fabricated on silicon wafers using stan-
dard photolithography methods98. Two layers of approximately 200 μm thickness were spun
and baked before exposure and development. Before use, the structures were silanized using
1H,1H,2H,2Hperﬂuorooctyl trichloro silane (Sigma) as previously described99. The wafers
were spin coated with PDMS (RTV615, General electric, 60 s at 150 r.p.m. and 120 s at 350
r.p.m.). The coated wafer was degassed for 5 min and left to reﬂow for 25 min at room temper-
ature before baking for 30 min at 80 ◦C. This process resulted in a perforated membrane of
~200 μm thickness. The membrane had 48 wells of 1 mm of diameter with a pitch of 2.25 mm.
The patterned PDMS was cut from the wafer and transferred to glass microscope coverslips.
Separately, an array of BSA that matched the pitch of the membrane was spotted onto an
epoxy covered microscope slide. The membrane wells on the coverslip were manually aligned
to the BSA spots on the slide using a stereoscope, providing a simple method to ensure
alignment between the arraying robot and the microfabricated substrate. For some samples, a
PDMS frame surrounding the membrane was manually cut and bonded to the coverslip using
oxygen plasma. This frame provided an efﬁcient medium container around the membrane
and enabled high-resolution imaging of the coverslip-supported cell array. Samples were
UV light–sterilized after assembly and coated with ﬁbronectin (Sigma) either by spotting a
concentrated suspension (1 mg/ml) or by 1-h incubation in a dilute solution (50 μg/ml).
The 675-well array plastic substrates were purchased from ALine, Inc. The arrays consisted of a
500 μm acrylic layer and a 50 μm silicone adhesive layer. They had wells of 1 mm diameter with
1.5 mm pitch and were adhered to glass microscope slides by passing them slowly through
lamination rollers at 60 ◦C. Arrays were not treated with ﬁbronectin before cell spotting.
2.5.2 Cell culture
Cells were cultured in Dulbecco’s modiﬁed Eagle medium (DMEM) supplemented with 10%
FBS and 1% penicillinstreptomycin at 37 ◦C and 5% CO2. For long-term assays, medium
supplemented with antibiotic-antimycotic was used. Cells were passaged every 2 d using
TrypleE express or trypsin. All culture reagents were acquired from Gibco (Life Technologies).
NIH-3T3 ﬁbroblasts stably expressed GFP or tdTomato ﬂuorescent protein, whereas CHO
and HEK293 cells expressed GFP (100% and 50% of the cells expressing ﬂuorescent protein,
respectively). Other cell lines used included Hep G2 cells, human MSCs and wildtype CHO
cells.
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2.5.3 Cell spotting
Cells were collected from T75 or T25 ﬂasks and washed. After cells were adjusted to the desired
concentration, they were transferred to 500 μL Eppendorf tubes in 20-μL aliquots. These
aliquots were centrifuged at 300g for 3 min and resuspended in a Percoll standard solution
(700 μL Percoll (Sigma), 100 μL 10x PBS (Gibco) and 200 μL Milli-Q water). For longer spotting
programs, 10x PBS was replaced with 10x DMEM. Cells resuspended in Percoll were plated in
5-μL aliquots onto conical-well, poly(propylene) 384-well plates (Arrayit). Cells were spotted
using a pin with a 100-μm-wide channel, a 1.25 μL uptake volume and a nominal 1.5 nl transfer
volume (WCMP, Arrayit). Spotting parameters were 2 x 1 s inking time, 2 x 1 s print time per
well. The washing protocol consisted of four alternating washes with ethanol and water. The
ﬁrst three washes were 2 s each, and the last wash was 5 s, with 5 s of drying after the last
wash. Including spotting and washing, the total time per sample was approximately 30 s, and
therefore an array of 48 different samples was completed in under 25 min. Before spotting,
the 48-well PDMS arrays were preﬁlled by manual pipetting ~0.5 μL of 0.7x culture medium
into each well. For the 675-well arrays, wells were preﬁlled by submerging the entire array in
0.7x medium. Air bubbles were removed from wells by pipetting. The array was then slowly
removed from the medium, and excess liquid was wiped from the surface. The same printing
conditions used for the 48-well array were used for the 675-well array, but only with one 1.5 s
water wash and 3 s of drying. During spotting, the humidity in the chamber was set to 70% to
reduce evaporation of medium from the wells without causing the printing malfunction that
is observed at higher humidity.
2.5.4 Array culture
Immediately after spotting, substrates were placed in a petri dish that contained warm Milli-Q
water to prevent evaporation during transport to the incubator and during cell attachment.
To preserve the integrity of the array, the samples were placed on a PDMS block adhered at
the center of the dish, ensuring that the water contained in the dish did not come in contact
with the sample. After incubation at 37 ◦C (1 h for the 48-well array and 3 h for the 675-well
array) the cell arrays were covered in medium for culture. To this end, either the coverslip was
detached from the epoxy slide and placed in a different petri dish or, for samples with a PDMS
frame, medium was directly added to the array.
To prepare arrays for freezing, LMCAs were placed in small plastic containers containing
90% FBS and 10% DMSO. The container was then placed into a cryobox with isopropanol,
and frozen at -80 ◦C overnight. The arrays were thawed by submersion in a beaker of PBS
contained in a 37 ◦C water bath. Once thawed, arrays were washed three times in culture
medium to remove residual DMSO.
For primary cell arrays, hMSCs were spotted onto a 48-well PDMS array following the pro-
cedure used for other cell types. hMSC proliferation medium consisted of alpha-minimum
essential medium (Invitrogen), 10% FBS (Hyclone), 1 ng/ml ﬁbroblast growth factor 2 (FGF2;
25
Chapter 2. Live mammalian cell arrays
R&D Systems), 2 mM l-glutamine (Sigma-Aldrich) and 1% penicillin-streptomycin (Invitro-
gen). Adipogenic differentiation medium contained low-glucose DMEM (Invitrogen), 20% FCS
(Hyclone), 0.5 mM 3-isobutyl-1- methylxanthine (IBMX; Sigma-Aldrich), 60 μM indomethacin
(Fluka) and 1 μM dexmethasone (Sigma-Aldrich). The arrays were ﬁxed in 4% paraformalde-
hyde for 15 min at room temperature. The PDMS membrane was removed before cell staining.
Nuclei were stained with a 10 μg/ml solution of DAPI (SigmaAldrich) in PBS. Lipid vesicles
were stained with a 1 μg/ml solution of Nile Red (Sigma-Aldrich) in PBS. The cell cytoskele-
ton was visualized by staining with phalloidin–Alexa Fluor 488 (Invitrogen) according to the
manufacturer’s instructions.
2.5.5 Transfection
For the reverse-transfection approach, glass slides coated with poly(l-lysine) (Electron Mi-
croscopy Sciences) were used. We diluted 0.37 μL DNA (at 1.8 μg/μL into 11.13 μL of a dextran
solution. We added 2 μL Fugene (Roche), and the mixture was incubated for 15 min. Then, 46
μL polyvinyl alcohol (PVA) was added, and the mixture was spotted into the nanowells using
a pin with a 500-μm-wide channel, a 1.25 μL uptake volume and a 15–25 nl transfer volume
(WCMPL, Arrayit). Arrays were allowed to dry, after which cells were introduced into the
nanowells by manual pipetting. Spotting conditions for the lipid-DNA mixture were identical
to those used for cells except that only one water wash (1 s) with 3 s drying was used between
samples, and three stamps per well were implemented. Dextran (Mr~40,000, Sigma) was
prepared at 45 mg/ml and PVA (molecular weight, 25,000; Polysciences) was prepared at 0.5%
(v/v) as described95. For regular transfection, cells were spotted as previously described. Two
hours after spotting, a lipid-DNA mixture was prepared and spotted into the nanowells as
described above, with the modiﬁcation that ﬁbronectin (1 mg/ml) was used instead of PVA.
Regular transfection arrays were not submerged in medium until 20 h after initial cell spotting.
2.5.6 Array imaging
Imaging of the 48-nanowell array was performed on a Nikon Ti automated microscope using
custom-written software to determine the positions to image trigonometrically and acquire
the multichannel images. Images were typically acquired using 10x magniﬁcation to capture
an entire well in the ﬁeld of view. Array images were collaged using ImageJ. ImageJ was also
used for cell counting. First, images where thresholded and inverted. Then, single cells were
counted using the particle analysis functions. Cells that were aggregated or too close for
direct counting were counted by measuring their area and calculating the number using a
proportion obtained from manual counting of a group of cells from the same sample. DAPI-
stained hMSCs were counted using the count nuclei program of Metamorph. Imaging of the
675-nanowell array was performed on a Nikon TI automated microscope using NIS Elements.
Each well was imaged with a 4x objective in brightﬁeld and ﬂuorescence mode. The resulting
675 images were ﬁrst brightness-adjusted and converted to jpeg format from tiff format, and
then stitched together using the Grid/Collection Stitching plugin in Fiji100.
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3.1 Abstract
Mammalian synthetic biology could be augmented through the development of high-throughput
microﬂuidic systems that integrate cellular transfection, culturing, and imaging. We created
a microﬂuidic chip that cultures cells and implements 280 independent transfections at up
to 99% efﬁciency. The chip can perform co-transfections, in which the number of cells ex-
pressing each protein and the average protein expression level can be precisely tuned as a
function of input DNA concentration and synthetic gene circuits can be optimized on chip.
We co-transfected four plasmids to test a histidine kinase signaling pathway and mapped the
dose dependence of this network on the level of one of its constituents. The chip is readily
integrated with high-content imaging, enabling the evaluation of cellular behavior and pro-
tein expression dynamics over time. These features make the transfection chip applicable to
high-throughput mammalian protein and synthetic biology studies.
3.2 Introduction
Reverse transfection assays have the potential to analyze the entire proteome in the natural cel-
lular context. Unlike protein microarrays, this method does not require individual puriﬁcation
of each protein16,34,35. Instead, reverse transfection arrays utilize puriﬁed cDNA samples33.
The array is seeded with cells, which upon transfection converts the cDNA into protein. Arrays
can also be made of siRNA to perform loss-of-function studies. With a pitch of approximately
400 μm, more than 5,000 samples can be printed on a single glass microscope slide33,36. A
recent study was able to further increase this density, printing spots just 150 μm apart37. This
throughput is especially important in light of ongoing efforts to screen genome-wide RNAi
libraries38 and cDNA libraries39. With the accumulation of data from cDNA microarrays
and whole genome sequencing, there is a need to validate protein function and characterize
therapeutic targets.
Reverse transfection could also serve as a valuable tool for synthetic biology. Synthetic biology
is often performed in prokaryotic models because of the ease with which prokaryotes can
be genetically modiﬁed and interrogated. Engineering mammalian systems remains more
difﬁcult, but mammalian synthetic biology is posed to impact biotechnology such as protein
production and provide novel therapies through stem cell engineering40,42. However, the lack
of high-throughput tools to efﬁciently deliver genetic material to mammalian cells is slowing
down progress. Mammalian synthetic systems can be complex and require multiple constructs
to be simultaneously delivered at precise ratios, necessitating painstaking optimization of the
transfection conditions43,44. Reverse transfection could provide a solution to this problem,
but to date it has not been adapted for this purpose.
Although reverse transfection has applications in many ﬁelds and is easily scalable, the method
involves manual cell seeding and culturing. Moreover, spots on the live cell array are not
physically separated from one another. These conditions preclude precise control over the cell
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environment and increase the likelihood of cross-contamination, to the extent that attempts
have been made to separate DNA spots with silicon gaskets and cell-repellent coatings49,50.
The integration of transfected cell arrays with microﬂuidics could eliminate these concerns,
enabling long-term experiments and studies using poorly adherent or highly migrant cell types.
Nevertheless, microﬂuidic transfection devices have yet to reach the impressive throughput
of the original reverse transfection microarrays. In a recent method developed by Schudel
et al., a separate microﬂuidic channel was required to introduce each lipid-DNA sample,
allowing a maximum of 8 unique transfections to be performed on chip56. In another study, a
lipid-DNA array was generated and aligned to an 8-chamber chip57. However, this system was
not designed to replenish medium in the transfection chambers, thus prohibiting long-term
experiments or ﬂow manipulation.
In this article, we present a platform that combines reverse transfection with microﬂuidics.
Up to 280 independent transfections can be performed per chip, with transfection efﬁciencies
of up to 99% and minimal cross-contamination. The use of a microarrayer to deposit DNA
constructs signiﬁcantly increases throughput, while the microﬂuidic environment permits
transfection, long-term culturing and manipulation of transfected cells. The setup can be
continuously imaged, enabling time-lapse studies. We thoroughly characterized our new
integrated microﬂuidic reverse transfection array and applied it to synthetic gene circuits.
3.3 Results
3.3.1 Device design and cell loading/culturing
Standard reverse transfection has been used by various groups with transfection efﬁcien-
cies ranging from 13 to 80%51–53. We sought to create a highly reproducible and efﬁcient
reverse transfection microﬂuidic platform that supports more complex experiments. Our
high-throughput chip design (Fig. 3.1a, 3.2a) measures 1.6 x 5.8 cm and contains 280 cell-
culturing/transfection chambers. A low-throughput chip containing 80 chambers was also
used (Fig 3.2b). The chips are aligned to DNA arrays so that each of the cell chambers contains
a unique transfection reaction. Cell loading takes no more than 10 min and consists of two
steps: ﬁrst, a suspension of HEK 239T cells is ﬂowed through the channels, and second, the
channels are segmented into individual chambers by valves (Fig. 3.3). Up to 600 cells can be
cultured in each chamber (diameter: 500 μm, and height: 30 μm; Fig. 3.1b).
To achieve both high cell viability and uniform cell density throughout the chip, we loaded
segments of the chip sequentially and at low ﬂow velocity. In contrast, an un-segmented chip
requires high loading speed to prevent clogging, and this velocity has been shown to decrease
cell viability101. Our layout permits the loading of 5 columns at a time (Fig. 3.1c). Each of these
subsections can be addressed individually, making it possible to load the device with different
cell densities or even different cell types. A loading rate of 7.2 μL/min (volume of medium
29
Chapter 3. A high-throughput microﬂuidic platform for mammalian cell transfection
and culturing
Figure 3.1. High-throughput microﬂuidic cell culturing and transfection chip. (a) Schematic
of the 280-chamber valve perfusion chip. (b) The different layers of the device were patterned
in photoresist. Close-up images show the sieve design (left) and the valve design (right). (c)
The chip is loaded in segments of 5 chambers. (d) COMSOL model showing the ﬂow velocity
proﬁle of the valve design (Scale: m/s). (e) COMSOL model showing the diffusion of nutrients
into the center of the chamber using a 13.4 kDa protein with a diffusion coefﬁcient of 1.14 x
10-6 cm2/s as an example. The extent of diffusion (0-1) is indicated.
exiting the chip over time) is used for the low-throughput chip. Due to an increased number
of features, the high-throughput chip requires a ﬂow rate of 27.3 μL/min in order to achieve
the same linear velocity through the channels.
Cell culturing is performed in a shear-free manner to reduce cross-contamination, mini-
mize cell stress, and increase compatibility of the device with weakly or non-adherent cells.
Although shear-free microﬂuidic perfusion systems have been designed64,102,103, most are
limited in throughput because chambers are not separated from one another. In our 80 and
280-chamber devices, we perfused medium at a rate of 8-17 μL/min through supply channels
that run parallel to the cell chambers, eliminating sheer stress (Fig. 3.1a). 5 μm high sieves or
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Figure 3.2. Design of the high-throughput cell culturing and transfection chip (sieve version).
(a) Design of the 280-chamber chip with sieves for medium perfusion. The chip measures
1.5 x 5.7 cm. Refer to Figure 3.1b for legend. (b) Design of the 80-chamber chip with sieves
for medium perfusion. The chip measures 1.2 x 4.1 cm. Refer to Figure 3.1b for legend. (c)
COMSOL modeling shows that diffusion of nutrients into the center of the cell chamber is
92% complete after 5 h. A 13.4 kDa protein with a diffusion coefﬁcient of 1.14 x 10-6 cm2/s was
used as an example.
30 μm high valves connect the ﬂow channels and culturing chambers, preventing cell escape
from the chambers during medium perfusion (Fig. 3.1b). Diffusion through the sieves or
valves (when opened) introduces nutrients and eliminates waste from the chambers.
COMSOL modeling veriﬁed that ﬂow through the chambers was nonexistent (Fig. 3.1d).
According to the model, near-complete diffusion of medium from the side channels to the
center of the chambers occurs after 5 h for the sieve design (Fig. 3.2c) and 5 min for the valve
design (Fig. 3.1e). Since we were working with adherent HEK 239T cells, we chose to use the
valve design for most experiments. After pulse perfusing104 (see methods) for one hour, cells
adhere inside the chambers and the valves can remain open for optimal diffusion of nutrients.
Nevertheless we also tested transfection with the sieve chip, which can be used for weakly
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or non-adherent cells without the need for a pulse perfusion system. We found that due to
limited diffusion into the chambers of the sieve chip, the FBS used to prepare the culture
medium should be as fresh as possible (Fig. 3.4).
Figure 3.3. Schematic of cell loading and culturing on the low-throughput chip. Segments of
chambers containing 5 columns are loaded sequentially. Yellow indicates the trajectory of ﬂow
through the chip. Black crosses indicate valves that are closed. For the chip design containing
valves in the place of sieves (Fig. 3.1b), these valves remain closed during cell loading and are
opened during medium perfusion. The high-throughput chip is loaded in a similar manner,
the main difference being the number of chamber segments (7 instead of 4).
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3.3.2 Device assembly
Initial microﬂuidic cell culturing experiments were performed using low-throughput PDMS
chips that were bonded to glass slides by baking at 80 ◦C. For high-throughput chips with
densely packed features, the decreased surface area of PDMS available for bonding resulted in
frequent delamination of the chip from the glass. To resolve this issue, we investigated whether
oxygen plasma could be used to mediate binding between PDMS and DNA-glass arrays. To
our knowledge, oxygen plasma has not been used on glass slides patterned with biological
substances such as lipid-DNA complexes because the oxygen plasma could potentially destroy
the spotted material. We thus tested the effect of plasma on DNA arrays that were completely
exposed to plasma and also on arrays where the DNA spots were protected with a PDMS block
(Fig. 3.5). The plasma-treated arrays were seeded with cells and measured for transfection
efﬁciency. We found that 7 s plasma treatment, with or without the protective PDMS block, did
not affect the spotted DNA, as transfection efﬁciency was comparable to an array that was not
plasma treated (Fig. 3.5). The strong glass-PDMS bond resulting from plasma treatment can
sustain increased medium perfusion speeds and drastically enhances the structural stability
of the assembled device, which is critical for performing long-term experiments.
Figure 3.4. The effect of serum quality on transfection efﬁciency with the sieve device. Old
(freeze-thawed 3 times) FBS was used for transfection experiments on a 96 well plate and on
the sieve design chip. Transfection efﬁciencies of eGFP and tdTomato are indicated in the
composite ﬂuorescent images. Cells proliferate faster when no transfection reagent is present.
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Figure 3.5. Plasma treatment of lipid-DNA microarrays. tdTomato transfection arrays were
treated with oxygen plasma for 7 s before being seeded with cells. For some arrays, the lipid-
DNA spots were protected by a PDMS block that had been adhered to a glass slide immediately
before plasma treatment (no bake) or during an 80 ◦C bake (1.5 or 3 h). tdTomato transfection
efﬁciency is indicated for each composite ﬂuorescence image.
3.3.3 Generating a microﬂuidic-compatible reverse transfection array
Reverse transfection requires an arraying substrate that retains DNA, such as gamma-amino
propyl silane (GAPS) or poly-l-lysine (PLL). However, these surfaces are positively charged
and do not bind robustly to hydrophobic PDMS microﬂuidic chips. To develop a PDMS-
compatible substrate, we ﬁrst arrayed PLL, followed by arraying lipid-DNA complexes onto
the PLL spots (Fig. 3.6a). Arraying of PLL and lipid-DNA is automated and takes between 30
min and 2 h to complete.
Depending on the exact application, PLL-coated glass slides are fabricated using solutions
containing 25 μg/ml to 1 mg/ml PLL and various buffers105–109. Due to the large discrepancies
in protocols, we tested a range of PLL concentrations for microarraying (Fig. 3.6b). PLL arrays
were spotted with a standard lipid-DNA mixture and seeded with cells to test for transfection
efﬁciency. We obtained optimal results when depositing a 333 μg/ml PLL solution 4 times per
spot, resulting in spots containing ~22 ng/mm2 of PLL (Fig. 3.6b). The time delay between
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Figure 3.6. Generation of a microﬂuidic-compatible reverse transfection array. (a) Workﬂow
to fabricate the transfection device. (b) Optimization of the amount of PLL deposited during
microarraying. eGFP transfection efﬁciency is indicated for each composite ﬂuorescence
image. (c) Effect of the composition of the PLL spottingmixture on eGFP transfection efﬁciency.
The images on the left of each set represent the full assembly (PLL spotted array + DNA array +
chip). The images on the right of each set represent the assembly without the chip (PLL spotted
array + DNA array). A standard reverse transfection array (evenly coated PLL + DNA array) was
also tested. eGFP transfection efﬁciency is indicated for each composite ﬂuorescence image.
(d) Comparison of tdTomato transfection efﬁciency using a standard GAPS slide or our spotted
PLL slide. Transfection efﬁciencies are indicated for the composite ﬂuorescence images.
each of the 4 spotting cycles did not considerably alter transfection efﬁciency (Fig. 3.7a).
Arrays were washed after arraying to remove excess PLL, and the time elapsed between array
completion and washing did not signiﬁcantly affect array quality (Fig. 3.7b).
35
Chapter 3. A high-throughput microﬂuidic platform for mammalian cell transfection
and culturing
???? ???? ???? ????
? ??????? ??? ??? ??????????
? ?? ?? ??? ?? ??? ??
???? ???? ????
??????
??????
Figure 3.7. Optimization of PLL spotting. (a) The amount of time elapsed between each of
the 4 PLL spotting cycles has little effect on eGFP transfection efﬁciency, as indicated by the
composite ﬂuorescent images. (b) The amount of time elapsed between array completion and
array rinsing to remove excess PLL has little effect on eGFP transfection efﬁciency, as shown
on the composite ﬂuorescent images.
We next optimized the chemical composition of the PLL spotting solution, testing recipes de-
rived from oligonucleotide microarraying protocols as well as tissue adhesion protocols109,110
(Fig. 3.6c). To examine the differences between standard and microﬂuidic transfection, we
ran a control array that lacked the microﬂuidic chip. Arrays made with a water-PBS mixture
that is typically used to prepare microarrays yielded very low transfection efﬁciency. When
we spotted PLL diluted in pH-adjusted 0.1 M boric acid, we achieved moderate transfection
efﬁciency on chip (37%) that corresponded well to the efﬁciency of the control array lacking
a chip (48%) (Fig. 3.6c). These results were also comparable to the 47% efﬁciency obtained
when spotting DNA on an evenly coated PLL slide, which is the standard substrate for reverse
transfection.
In addition to identifying the optimal buffer-PLL mixture for on-chip transfection, these
experiments also revealed differences in the nature of on-chip vs. standard array setups.
The control array lacking a chip yielded efﬁciencies of 48-65% for all PLL mixtures spotted
(Fig. 3.6c). On chip, depending on which buffer-PLL mixture was used, transfection efﬁciency
ranged from 11 to 37% (Fig. 3.6c). There was also a stark difference between the chip and
control arrays for positions where no PLL was deposited beneath the lipid-DNA. On the control
array, this spot yielded a transfection efﬁciency of 65% (Fig. 3.6c). In contrast, the same array
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aligned to a chip had just 6% efﬁciency (Fig. 3.6c). These ﬁndings indicate that the presence of
PLL is crucial for the success of on-chip reverse transfection.
We also tested our optimized PLL arrays alongside commercial GAPS (gamma-amino propyl
silane) slides, which are the standard substrate for reverse transfection, and found that both
PLL and GAPS substrates performed equally well (Fig. 3.6d). Compared to the manual batch
coating method, our PLL arraying method is simple and precise because an automated mi-
croarrayer is used to deposit the PLL. This method is also cost-effective since it requires 100
times less PLL than traditional coating. Moreover, when optimized, in-house coated PLL slides
have been shown to support higher and more consistent DNA retention than commercially
available slides111.
3.3.4 Microarraying and composition of transfection complexes
After optimizing the PLL arraying, we optimized transfection efﬁciency by varying the compo-
sition of the lipid-DNA mixture. We ﬁrst used the standard gelatin-containing recipe to prepare
lipid-DNA complexes for reverse transfection33,52,53,112. When this mixture was deposited
on the PLL arrays and used in combination with a PDMS chip, 13% efﬁciency was achieved
(Fig. 3.8a). We next included ﬁbronectin, which has been previously reported to increase trans-
fection efﬁciency48. When used with the PLL arrays, the ﬁbronectin-containing transfection
mixture resulted in 77% efﬁciency (Fig. 3.8b, Table 3.1). When the gelatin-ﬁbronectin mixture
was used in combination with optimized DNA concentration and PLL arrays, we were able to
obtain a very high transfection efﬁciency of 99% (Fig. 3.8c, Table 3.1). Moreover, different types
of cells can be cultured and transfected on the chip. Using an array optimized for HEK cells,
we were able to transfect CHO cells at a rate of 25% (Fig. 3.9a). The transfection efﬁciency can
likely be improved by optimizing the protocol for speciﬁc cell types.
Figure 3.8. Optimization of the lipid-DNA composition. (a) Microﬂuidic transfection ar-
rays were prepared using mixtures containing eGFP plasmid DNA, Effectene, and gelatin.
eGFP transfection efﬁciency is indicated for the composite ﬂuorescence image. (b) As in (a),
but including ﬁbronectin in the transfection mixture. (c) As in (a), but using a higher DNA
concentration and an optimized PLL array.
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Figure 3.9. Adapting the microchip to different cell types and transfection methods. (a) CHO
cells are transfected with eGFP on chip at high efﬁciency when using conditions that were
optimized for HEK cells. Transfection efﬁciency is indicated on the composite ﬂuorescent
image (left). The ﬂuorescence image is shown on the right. (b) HEK cells are transfected with
eGFP on chip at high efﬁciency when using the gelatin-DNA method. Transfection efﬁciency
is indicated on the composite ﬂuorescent image.
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Table 3.1. Detailed composition of transfection mixtures used for optimization experiments.
In addition to generating lipid-DNA arrays, we also tested the gelatin-DNA reverse transfection
technique. For this method, we deposited spots containing a mixture of DNA, gelatin, and ﬁ-
bronectin. Effectene transfection reagent was introduced on chip, and transfection complexes
were allowed to form before cells were loaded. This method yielded high efﬁciency of 77%
(Fig. 3.9b) and conserves reagent. For the gelatin-DNA method 25 μL Effectene is required for
the entire 280-chamber chip or 90 nl per sample, whereas the lipid-DNA method requires 5 μL
per sample spotted. A similar amount is consumed by standard reverse transfection arrays,
while well plate transfections require signiﬁcantly more reagent (Table 3.2). Moreover, well
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12 well plate Chip (lipid-DNA)
Chip 
(gelatin-DNA)
RT array 
(gelatin-DNA)
RT array 
(lipid-DNA)
Effectene 
reagent (μl) 56
25 per chip 
(100s of 
reactions)
5
25 per array 
(1000s of 
reactions)
DNA (μg) 0.3 1.51.51.51.5
Table 3.2. Comparison of reagent requirements for various transfection methods. RT, reverse
transfection.
Figure 3.10. Investigating DNA cross-contamination on the transfection arrays. Testing DNA
cross-contamination by staining with Sybr Green dye. DNA + dye or dye alone were included
in the transfection mixture and spotted on a PLL array. Fluorescence scans were obtained
before and after washing the arrays with PBS on chip (chip wash) or immersing the arrays with
PBS in batch (control wash). Dashed circles indicate positions where nothing (DNA + Dye
section) or dye only was spotted.
plate transfection requires three reagent mixing steps to be performed separately for each
sample and manual addition of the samples to the wells. Microﬂuidic transfection using the
gelatin-DNA method requires just one manual dilution; arraying of the samples and addition
of the Effectene is automated. Despite this advantage, existing microﬂuidic and biochip
transfection systems have thus far not taken advantage of the gelatin-DNA method57,113.
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Figure 3.11. Determining the source and extent of contamination on the transfection arrays.
(a) Cells were loaded into a transfection chip either at a slow ﬂow speed of 0.8 μL/min (upper)
or a fast ﬂow speed of 5.2 μL/min (lower). Blue circles indicate that DNA was spotted in the
chamber. eGFP transfection efﬁciencies are indicated on the composite ﬂuorescence images.
(b) Fluorescence micrograph of a chip in which tdTomato transfection mixture was spotted in
every other chamber. White circles indicate contaminating cells.
3.3.5 Quantiﬁcation of cross-contamination
During culturing of the transfection chip, constant ﬂow of medium parallel to the cham-
bers decreases the probability of cross-contamination or communication between chambers
(Fig. 3.1d). However, cell loading requires direct ﬂow through adjacent chambers (Fig. 3.3),
and during this process lipid-DNA complexes could be detached from their original arraying
position and deposited in a chamber further downstream. To test this possibility we stained
the DNA with ﬂuorescent dye, spotting every other chamber of the array with DNA (Fig. 3.10).
One portion of the array was spotted with dye only. The control consisted of an array that
was gently immersed in PBS. The test array was aligned to a low-throughput chip and cell
loading (ﬂow speed of 5.2 μL/min) was simulated with PBS. For both the control and on-chip
PBS washes, the ﬂuorescent DNA spots were still visible on the arrays. Fluorescence was not
observed in adjacent positions where DNA was not spotted, indicating that high levels of DNA
cross-contamination did not occur. Our PLL arraying procedure is thus sufﬁcient to strongly
anchor the DNA to the glass surface.
Although these ﬁndings imply that lipid-DNA does not detach in signiﬁcant quantities from
the arrays, these experiments were performed in PBS without cells. It is possible that cells take
up lipid-DNA complexes as they traverse upstream chambers and ultimately settle in
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Figure 3.12. Cell loading speed and cross-contamination. The relationship between cell
loading speed and cross-contamination was tested using the bottom two rows of a low-
throughput chip. The left half of the rows (20 chambers) was loaded at a low speed of 0.8
μL/min, and the right half of the rows (20 chambers) was loaded at a higher speed of 5.2
μL/min. Transfection efﬁciencies are indicated for the composite ﬂuorescence images. Blue
circles indicate that DNA was spotted in the chamber.
chambers further downstream. To test this possibility we generated a low-throughput array
in which every other chamber was spotted with eGFP DNA. When loading at a low speed of
0.8 μL/min, average transfection efﬁciency across all chambers was 39% in the DNA-spotted
chambers and 12% in the non-spotted chambers (Fig. 3.11a, 3.12). Loading at a higher speed
of 5.2 μL/min resulted in transfection efﬁciency of 33% in the DNA-spotted chambers and 5%
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in the non-spotted chambers. It is likely that at slow loading speeds, cells have more time to
interact with the DNA spots and acquire more DNA while in transit. Using a loading speed of
7.2 μL/min we obtained extremely low cross-contamination when every other chamber was
patterned with tdTomato DNA (Fig. 3.11b). Of the 40 chambers not patterned with DNA, 6
were contaminated. Two chambers contained two tdTomato-expressing cells, and the other 4
chambers contained one tdTomato-expressing cell.
We also performed transfection on the high-throughput chip, transfecting each cell-loading
segment with either eGFP or tdTomato. We observed that all 280 chambers were transfected,
and at similar efﬁciencies (Fig. 3.13a, 3.14). Average transfection efﬁciency for all chambers on
the chip was 65% (Fig. 3.14). 10 eGFP chambers were contaminated with 1-3 tdTomato cells
(Fig. 3.13b). eGFP contamination in tdTomato-spotted chambers was slightly higher. However,
Figure 3.13. Transfection on the high-throughput chip. (a) Fluorescence micrograph of the
entire transfected 280-chamber chip (upper) and close-up (lower right). Close-up composite
ﬂuorescence images indicate tdTomato and eGFP transfection efﬁciencies. (b) Histograms
showing the extent of contamination on the transfected high-throughput chip. eGFP counts
were calculated using intensity-adjusted images.
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Figure 3.14. Transfection efﬁciencies on the high-throughput chip. (a) Heatmap showing the
distribution of transfection efﬁciencies for each chamber of the chip presented in Figure 3.13a.
(b) Close-up composite ﬂuorescence image of a chamber from (a) with low eGFP transfection
efﬁciency (row 4, column 32). Although a moderate number of cells express eGFP, overall
transfection efﬁciency is low due to the large number of cells in the chamber. (c) Average
transfection efﬁciencies for the chip presented in Figure 3.13a. (d) Distribution of transfection
efﬁciencies amongst tdTomato and eGFP chambers.
the expression level of eGFP in the contaminating cells was extremely faint compared to the
normal level of protein expressed by a transfected cell (Fig. 3.15a). The eGFP contamination
histogram shown in Figure 3.13b has been adjusted to reﬂect this (Fig. 3.15b). The adjusted
count reveals that 15 chambers were contaminated by eGFP cells, the majority of which
contained a single cell.
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Figure 3.15. Quantiﬁcation of eGFP contamination on the high-throughput transfection
chip. (a) Unadjusted images showing representative chambers transfected with eGFP (left)
and contaminated with eGFP (center) from the chip shown in Figure 3.13. Dashed yellow
circles indicate the positions of two weakly ﬂuorescent eGFP cells. The histogram on the right
indicates the total contamination count when including weakly ﬂuorescent cells. (b) Same as
(a), but after adjusting the threshold to exclude weakly ﬂuorescent eGFP cells.
3.3.6 Simultaneous delivery of multiple plasmids
Massively parallel transfection on chip should be useful for optimizing and characterizing
synthetic systems implemented in mammalian cells. Sophisticated gene circuits contain many
components placed on several plasmids that should be co-expressed at different levels, thus
the quantities of the different plasmids must be extensively and painstakingly optimized44,114.
To determine if our device could be used to optimize and characterize synthetic systems,
we used our high-throughput chip to transfect cells with tdTomato and eGFP DNA mixed at
different ratios. In all experiments the total amount of DNA was kept constant, since it has
been well-established that there is a speciﬁc concentration of DNA that supports maximal
transfection efﬁciency20,115. We tested each ratio in a total of 10 chambers, using two 5-
chamber segments of the chip (Fig. 3.1c) and analyzing them separately.
First, we evaluated the number of cells that were transfected with eGFP alone, tdTomato alone,
or both plasmids. As expected, we found that the transfection efﬁciency of each plasmid
correlated with its concentration in the co-transfection mixture (Fig. 3.16a). The number
of cells expressing both tdTomato and eGFP progressively increased as the Tom:GFP ratio
increased from 1:4 to 2:1, reaching a peak of 82% at the 4:1 ratio and decreasing at the 8:1 ratio
(Fig. 3.16a,e). This experimental setup can be used to ﬁnd the DNA ratio that maximizes the
number of cells expressing both plasmids.
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Figure 3.16. Ratios of protein expression and transfection efﬁciency during co-transfection
on the high-throughput chip. (a) Transfection efﬁciencies as a function of the Tom:GFP co-
transfection ratio. Each sample represents the average from 10 chambers patterned with a
speciﬁc Tom:GFP DNA ratio. Error bars show standard deviation. (b) Distribution of Tom:GFP
expression ratios. Bin edges span from Tom:GFP expression ratios of 1/6 (left) to 6/1 (right),
with increments of 1/0.5 or 0.5/1 (e.g. 1/6, 1/5.5, 1/5 . . . 5/1, 5.5/1, 6/1). Samples prepared as
in (a). (c) Plot indicating the median Tom:GFP expression ratio from each sample shown in
(b). Error bars show standard deviation. (d) Protein expression (measured by ﬂuorescence
intensity) as a function of the amount of DNA transfected. Samples were prepared as in (a).
Error bars show standard deviation. (e) Sample images for each Tom:GFP co-transfection DNA
ratio.
Next, we considered only the cells that expressed both proteins and evaluated their protein ex-
pression levels by measuring the ﬂuorescence intensities of tdTomato and eGFP. We observed
that protein expression ratios were dependent on the ratio of plasmid DNA used (Fig. 3.16b,c).
There was also considerable agreement between the two 5-chamber segments that served as
replicates of one another (Fig. 3.17). At more extreme ratios, we observed a weaker correlation
between the input DNA ratio and the actual protein expression ratio. For example, the 8:1 sam-
ple resulted in a 2.46:1 expression ratio while the 2:1 sample yielded a more predictable value
of 1.38:1 (Fig. 3.16c). Measured protein expression ratios are only relative values and likely
skewed from the true values since they are based on measured intensity, and the tdTomato
and eGFP ﬂuorophores have different intrinsic brightness. Nevertheless, these ﬁndings show
that it is possible to tune the expression ratios of proteins inside transfected cells.
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Figure 3.17. Ratios of protein expression and transfection efﬁciency for microﬂuidic co-
transfection. Distribution of Tom:GFP expression ratios for co-transfection ratios ranging
from 1:4 to 8:1. Bins span from Tom:GFP ratios of 1/6 (left) to 6/1 (right), with increments of
1/0.5 or 0.5/1 (e.g. 1/6, 1/5.5, 1/5 . . . 5/1, 5.5/1, 6/1). Each curve represents the averages from
one 5-chamber segment of this chip (Fig. 3.1c). The average of these two data sets was used to
generate the curves shown in Figure 3.16
When we processed the tdTomato and eGFP data separately, we observed a similar correlation
between the amount of DNA used for transfection and the level of protein expression. Increas-
ing the quantity of DNA used for transfection directly increases the ﬂuorescence intensity
in a manner that is similar for both tdTomato and eGFP (Fig. 3.16d). Therefore in addition
to co-transfection the transfection device can be used to produce precise levels of a single
protein, provided that a second empty plasmid is added to keep the total amount of DNA
transfected at the optimal level of 1.5 μg.
These on-chip results corroborated well with the data obtained from performing the same
experiment in 96 well and 6 well plate format (Fig. 3.16, 3.18, 3.19, 3.20). In contrast to the
reverse transfection array technique used on chip, for the well plates the transfection mixture
was added in solution to cells that had already been seeded. The ability of the on-chip results
to match the trends displayed by the well plate results assures that this technology can be used
interchangeably with standard cell culturing and transfection methods.
In addition to validating that on-chip transfection is comparable to well plate transfection,
we also validated our image analysis approach. To do so, we implemented the standard 6
well plate transfection method followed by ﬂow cytometry analysis. The ﬂow cytometry-
derived distribution of eGFP-only, tdTomato-only, and co-transfected cells displayed the
same dependency on DNA ratios that was seen with the data obtained by image analysis
(Fig. 3.16, 3.18, 3.19, 3.20). The relationship between co-transfection DNA ratio and protein
expression ratio was also similar, with ﬂow cytometry performing better at more extreme
ratios (Fig. 3.16, 3.19, 3.20). Image analysis thus can serve as a less complicated alternative to
ﬂow cytometry, as there is no need to harvest and prepare each cell sample.
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Figure 3.18. Ratios of protein expression and transfection efﬁciency for 96-well plate co-
transfection. (a) Transfection efﬁciencies as a function of the Tom:GFP co-transfection ratio.
Each sample represents the average from 2 wells (each imaged at 3 different positions) trans-
fected with a speciﬁc Tom:GFP DNA ratio. Error bars show standard deviation. (b) Distribution
of Tom:GFP expression ratios. Bin edges span from Tom:GFP expression ratios of 1/6 (left)
to 6/1 (right), with increments of 1/0.5 or 0.5/1 (e.g. 1/6, 1/5.5, 1/5 . . . 5/1, 5.5/1, 6/1). Sam-
ples prepared as in (a). (c) Plot indicating the median Tom:GFP expression ratio from each
sample shown in (b). Error bars show standard deviation. (d) Protein expression (measured
by ﬂuorescence intensity) as a function of the amount of DNA transfected. Samples were
prepared as in (a). Error bars show standard deviation. (e) Sample images for each Tom:GFP
co-transfection DNA ratio. Variance of the 96-well plate data from the on-chip data may be
due to slightly different imaging conditions (on-chip exposure times: 50 ms Tom, 70 ms GFP;
well plate exposure times: 50 ms Tom, 50 ms GFP.
3.3.7 Transfection of synthetic genetic circuits
Many different co-transfection ratios can be tested in parallel on the chip, facilitating opti-
mization and enabling high-throughput mammalian synthetic biology. To test the device with
a recently reported synthetic system, we implemented the two-component signaling (TCS)
system developed by Hansen et al114. The pathway consists of prokaryotic proteins DcuS and
DcuR116,117 that have been codon-optimized for expression in mammalian cells and are con-
stitutively expressed from a CMV promoter. Upon stimulation by C4-carboxylates present in
the cell culture medium, the membrane-localized histidine kinase (DcuS) autophosphorylates
its cytoplasmic domain (Fig. 3.21a). The phosphate is then transferred to DcuR, a
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Figure 3.19. Flow cytometry analysis for 6-well plate co-transfection. (a) Transfection efﬁ-
ciencies as a function of the Tom:GFP co-transfection ratio. Each sample represents 50,000
cells transfected with a speciﬁc Tom:GFP DNA ratio. (b) Plot indicating the median Tom:GFP
expression ratio from each co-transfection ratio shown in (a). (c) Flow cytometry plots.
transcriptional regulator that has been modiﬁed to contain three minimal VP16 transactivating
domains at the C terminus. Upon activation by phosphorylation, DcuR binds to the promoter
of the reporter plasmid and activates transcription of AmCyan. Various ratios of the three
plasmids were used for transfection on the high-throughput chip, and a fourth plasmid
(expressing tdTomato) was used as a transfection control. Activation of AmCyan expression
was observed for all ratios tested (Fig. 3.21b). Transfections lacking any one element of the
synthetic circuit did not produce AmCyan ﬂuorescence and only expressed the tdTomato
transfection control. We next tested the sensitivity of the system to changes in DcuS while
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Figure 3.20. Comparison of ratios of protein expression and transfection efﬁciency for vari-
ous co-transfection and analysis methods. (a) Transfection efﬁciencies as a function of the
Tom:GFP co-transfection ratio, as previously shown in Figure 3.16a, 3.18a, 3.19a. (b) Plots
indicating the median Tom:GFP expression ratio from each sample shown in (a).
keeping DcuR and the AmCyan reporter at ﬁxed quantities.
We found that maximal AmCyan induction occurs when DcuS represents 2% of the total 3-
plasmid transfection mixture and decreases below the optimal DcuS concentration (Fig. 3.21c).
This ﬁnding is in agreement with the original study, which implemented transfections in
12-well plates followed by ﬂow cytometry analysis of protein expression. We additionally
performed the experiment in 96-well plate format followed by image analysis of protein
expression and obtained similar results (Fig. 3.22). Our microﬂuidic transfection and image
analysismethod is thus capable of reproducing the results obtained from standard transfection
and ﬂow cytometry techniques.
We also performed time-lapse experiments to visualize the changes in protein expression over
the course of transfection. Expression of the tdTomato transfection control began immediately
post transfection (Fig. 3.21d,e, Supplementary Movie 1). AmCyan expression was ﬁrst detected
12 h post transfection (Fig. 3.21d,e, Supplementary Movie 2). Assuming that tdTomato and
AmCyan have similar maturation times118,119, this time lag can be explained by the fact that
DcuS and DcuR must ﬁrst be transfected and expressed before they can activate expression of
AmCyan (Fig. 3.21a). For both tdTomato and AmCyan, protein expression levels continued
to increase steadily until 53 h post transfection (Fig. 3.21d,e, Supplementary Movies 1, 2).
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Figure 3.21. Measuring the dynamics of synthetic gene circuits on the high-throughput
chip. (a) Schematic of the two-component signaling pathway. The histidine kinase (DcuS)
is activated by ligand binding and transmits the signal to DcuR, a DNA-binding protein. P,
phosphate; VP16, VP16 transactivator domain, DNABS, DNA binding sites. (b) Representative
ﬂuorescence images with DcuS amounts indicated in ng. Reactions included 296 ng tdTomato
and, aside from the negative controls, 444 ng DcuR and 665 ng DcuR-RE. (c) Brightness of the
reporter as a function of histidine kinase concentration for the original 12-well setup114 and
for the microﬂuidic setup. For the microﬂuidic data, points are the average of 10 chambers.
Brightness is normalized so that the maximum occurs at 1. (d) Dynamics of tdTomato and
AmCyam protein expression over time. The sample contained 296 ng tdTomato, 59 ng DcuS,
444 ng DcuR 665 ng DcuR-RE. The average brightness of two 5-chamber segments of the chip
was calculated separately, and shaded areas represent the standard deviation between these
two values. Maximum brightness is 1. (e) As in (d), but with brightness normalized so that the
maximum occurs at 1.
These results support the standard practice of acquiring images after 48 h, when transfection
efﬁciency and protein expression are high. Because our microﬂuidic technology is compatible
with high-content imaging, samples can be monitored continuously, allowing signiﬁcantly
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Figure 3.22. Measuring the dynamics of synthetic gene circuits for 96-well plate transfec-
tions. (a) Schematic of the two-component signaling pathway. The histidine kinase (DcuS)
is activated by ligand binding and transmits the signal to DcuR, a DNA-binding protein. P,
phosphate; VP16, VP16 transactivator domain, DNABS, DNA binding sites. (b) Representative
ﬂuorescence images with DcuS amounts indicated in ng. Each well of a 96-well plate was
transfected with 13 ng tdTomato DNA and, aside from the negative controls, 38 ng DcuR and
56 DcuR-RE DNA. (c) Brightness of the reporter as a function of histidine kinase concentration
for the original 12-well setup114, for the microﬂuidic setup, and for the 96-well plate setup.
For the microﬂuidic data, points are the average of 10 chambers. For the 96-well plate data,
points are the average of 6 images originating from 2 wells. Brightness is normalized so that
the maximum occurs at 1. Variance of the 96-well plate data from the on-chip data may be
due to slightly different imaging conditions (on-chip exposure times: 100 ms Tom, 100 ms
cyan; well plate exposure times: 50 ms Tom, 50 ms cyan).
more data to be collected compared to end-point methods such as FACS.
3.3.8 Supplementary Movies
Supplementary movies (53 h continuous monitoring of tdTomato expression, AmCyan expres-
sion, and growth in brightﬁeld) are available at: http://www.nature.com/articles/srep23937
3.4 Discussion
We developed a high-throughput microﬂuidic platform capable of 280 independent transfec-
tions at up to 99% efﬁciency with HEK 293T cells. In comparison, other biochip platforms
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obtained between 13% and 80% transfection efﬁciency51–53, while throughputs ranged be-
tween 1 to 96 reactions per device54–57. The transfection reactions on our chip are conﬁned to
separate chambers, decreasing the risks of cross-contamination and communication between
different positions on the array. This segregation, combined with the chip’s ability to automate
long-term cell culture, has the potential to overcome the limitations of reverse transfection
microarrays. Microﬂuidic platforms are easily adapted to high-content imaging88–90, and the
reduced sample requirement enables the study of cells that are available in limited quantities.
The behavior of cells over time can further be monitored in response to ﬂuidic stimuli such as
change of the culturing medium or introduction of a drug58. By implementing a recently devel-
oped synthetic two-component system we show that our integrated microﬂuidic transfection
platform can be used to optimize and study synthetic circuits. Overall, the high-throughput
microﬂuidic transfection and cell-culturing platform we demonstrate here should be a useful
tool for mammalian cell engineering.
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3.5 Methods
3.5.1 Microarray printing and slide treatment
Prior to arraying, glass slideswerewashed by shaking in a 57%Ethanol, 10%w/vNaOHsolution
for 2 h. The slides were thoroughly washed with Milli-Q water and dried before proceeding to
microarray printing. Glass slides etched with microwells in the positions of the cell chambers
were also explored in attempts to decrease cross-contamination, however the microwells were
difﬁcult to align with the microarrayer. The spotting pin tended to come in contact with the
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sides of thewells rather than the bottom, preventing sufﬁcient amounts of transfectionmixture
from being deposited into the bottoms of the wells. A QArray2 microarrayer (Genetix GmbH)
was used to array samples contained in conical-well, poly(propylene) 384-well plates (Arrayit).
Most solutions were spotted using a pin with a 300 μm spot diameter and 3.3 nl delivery
volume (946MP9, Arrayit). For the 2-component system, a 500 μm spotting pin was used
(946MP15, Arrayit). Spotting parameters for both lipid-DNA mixtures and PLL were 1 s inking
time, 500 ms printing time. Between samples, the pin was washed with water for 500 ms and
dried for 500 ms. Lipid-DNA was stamped once per spot. As has been previously reported52,
we found that stamping multiple times per spot resulted in imprecisely localized spots due to
spreading of excess DNA. Following microarraying, lipid-DNA arrays were immediately stored
in a desiccator.
PLL was stamped 4 times per spot in a cyclic fashion, with approximately 8 min between
cycles. 2 h after the arraying was complete, PLL arrays were thoroughly washed with ﬁltered
water, dried, and stored in a desiccator. PLL slides were used between 2 and 8 weeks post-
coating, since the quality of the PLL has been shown to decrease signiﬁcantly beyond this time
period111.
3.5.2 Microarraying mixture preparation
The PLL sample was prepared by adding 25 μL of 0.1% PLL solution (Sigma) to 50 μL of a
solution of 0.225 M boric acid, pH 8.4. Evenly-coated PLL slides were prepared according
to standard protocols109. The lipid-DNA method developed by Ziauddin et al.33 was used
to prepare transfection mixtures containing Effectene (Qiagen). First, 1.5 μg of supercoiled
plasmid DNA was diluted in 15 μL of EC buffer in which sucrose had been dissolved at a
concentration of 0.2 M. In the case of co-transfection, this mixture was vortexed for 10 s and
allowed to incubate for 15 min. Next, 1.5 μL Enhancer was added and the mixture was vortexed
for 1 s and incubated at room temperature for 5 min. Next, 5 μL Effectene was added and the
mixture was vortexed gently for 10 s and incubated for 10 min. Lastly, 12.7 μL of a 0.5% gelatin
solution (prepared from G9391, Sigma) and 12.7 μL of a 0.1% ﬁbronectin solution (F0895,
Sigma) were added and the samples were transferred to a 384-well plate for microarraying.
Human plasma ﬁbronectin could be replaced with bovine plasma ﬁbronectin (Sigma-Aldrich
F4759, powder dissolved in water at 1 mg/ml) with no decrease in transfection efﬁciency.
Samples for the gelatin-DNA transfection method were prepared similarly and contained a
mixture of 1.5 μg DNA and buffer EC (total of 25.4 μL), 12.7 μL gelatin, and 12.7 μL ﬁbronectin.
A mixture of 16 μL Enhancer, 150 μL EC buffer, and 25 μL Effectene was ﬂowed on chip for 30
min using the same conditions used for medium perfusion. Medium was ﬂowed on chip for
20 min before cell loading.
Co-transfection mixtures were prepared by modifying the ratios of each plasmid and keeping
total DNA content at 1.5 μg for each mixture. Attempts to co-transfect by co-spotting (se-
quential spotting of separately prepared transfection mixtures) and to achieve stable protein
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production via lentiviral transduction were unsuccessful (see Appendix).
3.5.3 Standard transfections
96-well plate transfections were performed by ﬁrst seeding each well with 10,000 cells the day
before transfection. Each well was transfected with 0.1 μg DNA diluted in EC buffer, 0.8 μL
Enhancer, and 2.5 μL Effectene (prepared according to manufacturer’s instructions). Images
were acquired and processed in the same manner used for on-chip experiments. 6-well plate
transfections were performed by ﬁrst seeding each well with 200,000 cells the day before
transfection. Each well was transfected with 0.4 μg DNA diluted in EC buffer, 3.2 μL Enhancer,
and 10 μL Effectene (prepared according to manufacturer’s instructions). Cells were harvested
and subjected to analysis by ﬂow cytometry.
3.5.4 DNA staining
A 100x dilution of YOYO-1 dye (Life Technologies) was prepared in DMSO (Sigma). The YOYO
dilution was added to the complete lipid-DNA transfection mixture to result in a ﬁnal 10,000
fold dilution. The transfection-dye mixture was incubated for 60 min before microarraying.
The stained arrays were visualized by using an ArrayWorx scanner (Applied Precision).
3.5.5 Cell culture
All culture reagents were acquired from Gibco (Life Technologies). Cells were cultured at
37 ◦C and 5% CO2 in Dulbecco’s modiﬁed Eagle medium (DMEM) supplemented with 10%
FBS and antibiotic-antimycotic. Cells were passaged every 2-3 days using TrypleE express.
For on-chip experiments, cells were grown in CO2 independent medium supplemented with
GlutaMAX, 10% FBS and antibiotic-antimycotic. Microﬂuidic chips were cultured on the stage
of a microscope contained within an incubation chamber (Life Imaging Services) maintained
at 37 ◦C.
3.5.6 Flow cytometry
48 h after transfection, cells were trypsinized and resuspended in PBS. For analysis, a BD
LSRII was used with the following settings: for eGFP, a 488 nm laser and a 525/50 ﬁlter with
a photomultiplier tube (PMT) voltage of 225, for tdTomato: a 561 nm laser and 585/15 ﬁlter
with a PMT voltage of 379. 50,000 events were measured per sample.
3.5.7 Imaging
Imaging of the microﬂuidic transfection arrays was performed on a Nikon Ti-E Eclipse auto-
mated microscope using NIS Elements. Images were acquired with an Ixon DU-888 camera
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(Andor Technology), using 20x magniﬁcation to capture an entire chamber in the ﬁeld of
view. Each chamber was imaged in brightﬁeld and ﬂuorescence mode. Three HC ﬁlter cubes
were used: TexasRed (HC 562/40, HC 624/40, BS 593) for tdTomato, FITC (HC 482/35, HC
536/40, BS 506) for eGFP, and CFP (HC 438/24, HC 483/32, BS 458) for AmCyan (all from AHF
Analysentechnik AG). Images were stitched together using the Grid/Collection Stitching plugin
in Fiji100. Cells were counted using the “Load Images”, “Crop”, “Identify Primary Objects”,
and “Measure Image Area Occupied” modules of CellProﬁler120 or by using a custom written
Matlab script (see Appendix).
Transfection efﬁciency was calculated as the area occupied by ﬂuorescent cells in the entire
chamber (500 μm diameter) divided by the area occupied by cells within the 300 μm diameter
spot where the lipid-DNA was deposited. This normalization is necessary because following
cell loading into the chambers, only some of the cells have access to the transfection mixture
(a 300 μm spot within a 500 μm chamber). Some cells that initially settle in the lipid-DNA area
migrate to different parts of the chamber after 48 h (when images are captured), resulting in
the dispersed pattern visible in the images.
3.5.8 COMSOL modeling
COMSOL Multiphysics was used to build a 2D representation of the microﬂuidic cell culturing
chambers. The modules laminar ﬂow and transport of diluted species were used. Cytochrome
C, a 13.4 kDa protein with a diffusion coefﬁcient of 1.14 x 10-6 cm2/s, was used to model the
transport of diluted species.
3.5.9 Microﬂuidic device fabrication
Microﬂuidic devices were designed in Clewin (WieWeb software, Netherlands). Two molds
were designed: one for the control layer, which contains the valves, and another for the ﬂow
layer, which contains the channels and chambers necessary for reagent introduction and
cell culturing. The control layer was scaled by 101.5% to account for PDMS shrinkage during
curing.
The molds were fabricated using standard photolithography methods. The control layer mold
was patterned with SU-8 photoresist (Gersteltec, Switzerland) to a height of 30 μm. The ﬂow
layer mold for the sieve chip design (Fig. 3.2a) was fabricated in ﬁve steps. First, to create
alignment marks, AZ1512 positive photoresist (MicroChemicals GmbH) was spin coated to a
height of 1 μm, then exposed and developed. The alignment marks were etched to a depth
of 4 μm using inductively coupled plasma. The AZ1512 hard mask was then removed using
oxygen plasma. Second, a dummy layer of SU-8 was spin coated to a height of 2 μm, then
ﬂood exposed and developed. Third, sieves were created by spin coating SU-8 to a height
of 5 μm, followed by exposure and development. Fourth, ﬂow channels were generated by
spin coating SU-8 to a height of 30 μm, followed by exposure and development. Lastly, valve
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regions were patterned by spin coating AZ9260 (MicroChemicals GmbH) to a height of 30 μm,
then exposing and developing. The AZ9260 was annealed at 120 ◦C for 25 s to generate the
rounded proﬁle that is required for complete valve closure. The valve chip design (Fig. 3.1a)
was fabricated by performing only steps four and ﬁve of the protocol detailed above.
Polydimethylsiloxane (PDMS; Sylgard 184, Dow Corning Corp., USA) was cast onto the molds
and multilayer soft lithography techniques were used to assemble the chip121. A thick layer
of PDMS (5:1 ratio of parts A:B) was poured onto the control layer, whereas the ﬂow layer
was spin coated with PDMS (20:1 ratio of parts A:B) with a ramp of 15 s and a spin of 35 s at
650 rpm. The molds were baked for 30 min at 80 ◦C. The control layer chips were then cut,
removed from the mold, and punched with inlet holes. The control layer chips were aligned to
the ﬂow layer, and the assembly was baked for 90 min at 80 ◦C. The aligned devices were then
cut, removed from the mold, and punched with inlet and outlet holes. The PDMS chips were
bonded to the glass arrays by using 7 s of oxygen plasma treatment, followed by baking for 1 h
at 80 ◦C. Transfection devices were stored in a desiccator prior to use.
3.5.10 Microﬂuidic device operation
The pressures of the ﬂow and control layers of the chip were controlled by using a custom built
pneumatic setup. The valves of the control layer were ﬁrst primed with ﬁltered water at 5 psi.
Once all air had been removed from the control lines, the control layer pressure was increased
to 22 psi. Medium was ﬂowed through the chip prior to cell loading. A sample containing
800,000 cells in 20 μL PBS was purged through the chip inlets. After purging, the cells were
loaded into the ﬁrst set of columns at a speed of 7.2 μL/min for the low-throughput chip and
27.3 μL/min for the high-throughput chip. Flow rate was determined by measuring the volume
of liquid exiting the chip over a period of time. Columns were loaded in sets sequentially, and
the chamber-segmenting valves were actuated once loading for each set was complete. For
the sieve design, medium was immediately perfused at a rate of 1 ml/h (16.7 μL/min). For the
valve design, medium was pulse perfused for the ﬁrst hour. Medium was ﬂowed with chamber
valves closed (5 min) followed by stopping the ﬂow and opening the chamber valves (5 min).
After cycling between these two states for the ﬁrst hour, the chamber valves were opened
during continuous medium ﬂow of 1 ml/h. PTFE tubing was used for all ﬂuidic connections
because we observed some cell toxicity when using Tygon tubing, as has been previously
reported103.
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4.1 Abstract
We designed a microﬂuidic module that generates complex, dynamic concentration pro-
ﬁles of multiple molecules over a large concentration range using pulse-width modulation
(PWM). Our PWM device can arbitrarily combine up to 6 different inputs and select between
three downstream mixing channels as required by the application. The module can produce
arbitrary concentrations with a dynamic range of up to 3-5 decades. We created complex
concentration proﬁles of 2 molecules, with each concentration independently controllable,
and show that the PWM module can execute rapid concentration changes as well as long-
timescale pharmacokinetic proﬁles. Concentration proﬁles were generated for molecules
with molecular weights ranging from 560 Da to 150 kDa. Our PWM module produces robust
and precise concentration proﬁles under a variety of operating conditions, making it ideal for
integration with existing microﬂuidic devices for advanced cell and pharmacokinetic studies.
4.2 Introduction
In order to perform complex and biologically relevant experiments on microﬂuidic platforms,
there is a need for accurate and automated methods to manipulate molecular concentrations
on chip. Microﬂuidic devices are generally connected to a small number of input solutions.
Consequently, most experiments involve one or more step function changes, switching rapidly
from one molecule to another or from one concentration to another. In contrast, naturally
occurring changes in concentrations of molecules are rarely instantaneous step-functions.
Physiologically relevant changes, such as pharmacokinetic drug concentration proﬁles, occur
over minutes to hours and follow a complex, continuous rise and fall pattern. Complex tem-
poral concentration proﬁles of one or more substances could be used to study the inﬂuence
of changing antibiotic concentrations on bacteria, the effects of drugs on mammalian cells,
and stem cell differentiation. The ability to rapidly generate arbitrary and complex temporal
concentration proﬁles is thus of general interest and a useful experimental method.
One technique to create concentration proﬁles from two inputs involves lateral diffusion-
based gradients70,71. Two ﬂuids are simultaneously ﬂowed parallel to one another along the
length of a channel or chamber, establishing a gradient that is perpendicular to the direction
of the ﬂow. This principle has been used to design microﬂuidic devices capable of preparing
up to 81 chemical combinations69. However, the total possible outputs are highly dependent
on the number of inputs (16 stock solutions are needed to produce 81 different solutions) and
because this approach is diffusion-based, it offers poor spatio-temporal resolution. Several
active mixing techniques72 including mechanical micromixers73, microstructures74, inte-
grated peristaltic pumps75, and serial dilution schemes76 have been developed to provide
fast concentration changes. As with the gradient-based technique, the number of possible
concentrations on these devices is also limited and deﬁned by the number of solution inputs.
To generate small changes in concentration over a large dynamic range, dynamic strategies
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Figure 4.1. Schematic of microﬂuidic PWM. Circles represent one full pulse cycle. Yellow and
blue represent molecules of interest, gray represents diluting buffer.
such as pulse-width modulation (PWM) are necessary. PWM is based on the concept of
controlling the duty cycle of a load to control voltage and current in electrical engineering.
The microﬂuidic equivalent controls the ﬂow of buffer and substrate reservoirs (Fig. 4.1). A
microﬂuidic device that supports fast switching times can generate alternating pulses of buffer
and substrate. When directed through a channel, these pulses diffuse to homogeneity. Total
cycle time (time to execute one pulse of buffer and one pulse of substrate) is kept constant.
Different concentrations are created by varying the duty cycle, which refers to the fraction of
time occupied by the substrate pulse in comparison to the total cycle time.
PWM has been incorporated into microﬂuidic diluters in the past85–87,122. For a single
molecule of small size, previous examples have prepared solutions of speciﬁc concentra-
tions with high accuracy. The compatibility of these devices with proteins and substances
larger than small dye molecules has not been tested. Moreover, current PWM devices have not
demonstrated that complex patterns can be generated for multiple molecules simultaneously.
Another drawback is the large, non-standard dimensions of the mixing infrastructure; these
elements require additional cleanroom fabrication steps and occupy a signiﬁcant amount
of space on the chip. Lastly, previously reported PWM chips have performed experiments
lasting from a few minutes to 1.5 hours. It is unknown whether these devices are capable of
sustaining concentrations for extended time periods, as experiments spanning several hours
or days would be required for studies involving bacteria or mammalian cells.
Long-term concentration manipulation on microﬂuidic devices would also be interesting
for pharmacokinetic and pharmacodynamic (PK/PD) studies. These assays are central to
drug discovery and development80,81. Typical in vitro PK/PD models, while able to properly
reproduce the pharmacokinetics of drugs in vivo, provide only bulk measurements82. This
simpliﬁed setup poorly represents the complex in vivo environment and is not compatible
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Figure 4.2. The PWM platform. (a) Design of the PWM mixing chip. Red, control layer for
valve actuation; blue, ﬂow layer for ﬂuid manipulation. (b) Schematic of the PWM technique.
Pulses are created by alternating the opening and closing of inlets. The pulsed ﬂow pattern
diffuses to homogeneity in the serpentine channels.
with techniques that probe single cell phenotypes. Although microﬂuidic chips have been
designed to address this need83,84, these devices lack the ability to simulate the gradually
rising and falling concentrations of drugs in plasma. Ideally, a device should be able to create
realistic PK/PD proﬁles for multiple substances at once.
We have developed a microﬂuidic device that improves upon previous PWM-based chips,
making it compatible with a broad range of applications. Our device successfully implements
concentration changes over both short and long time scales, making it capable of producing
complex PK/PD proﬁles. The device occupies minimal space and its features can be fabricated
in one photolithographic layer. These characteristics facilitate integration of the module into
existing chip designs. We also show that the PWM device can function as an independent
module connected upstream of a second chip. The ability to easily modify total cycle times
and choose between 3 mixing channel options (short serpentine, long serpentine, and tubing
connection to a second chip) ensure that our chip can function with a variety of molecule
sizes and ﬂow rates. Two substances can be manipulated in parallel, and the chip supports a
dynamic range of nearly 3 orders of magnitude in output concentrations. These qualities make
our chip an attractive tool for chemical and biological research requiring complex proﬁles and
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will enable studies that were previously inaccessible because of technical limitations.
4.3 Results
4.3.1 PWM chip design and technique
Wedesigned amicroﬂuidicmodule (Fig. 4.2a) that performs PWM to mix up to 6 different input
solutions. The device measures 1.2 x 2.8 cm and was fabricated using standard photolithog-
raphy and soft lithography techniques. The valves controlling the ﬂow of these inputs were
engineered for fast actuation (<30 ms, Fig. 4.3) in order to accurately dispense short pulses of
each input solution. The input channels merge into a common channel, and the ﬂow can be
directed into one of three paths depending on the application. A short serpentine channel
(53 mm length, 0.074 μL capacity) facilitates diffusion-based mixing of small molecules and
most proteins as they travel along the channel. The long serpentine channel (255 mm length,
0.356 μL capacity) provides for the mixing of complex solutions or large proteins with small
diffusion coefﬁcients. Lastly, ﬂow can be directed into a short channel (8 mm length) and
subsequently connected to another chip via ﬂexible tubing. Merging of the pulses will occur
in the tubing, delivering a homogeneous solution to the connected chip.
To adjust the concentration generated on chip, we modiﬁed the amount of time that each
solution was ﬂowed to produce pulses of different lengths. Only one solution was ﬂowed at a
time, and both the ﬂow rate and the total cycle time (time to complete one round of pulses)
were kept constant (Fig. 4.2b). Of the 6 inputs, at least one was a buffer used for dilution.
The other 5 can be either 5 different substances (to prepare a complex mixture), the same
substance diluted to 5 different concentrations (to enable an expansive dynamic range), or
any combination of these two cases. We wrote a program that selects which inputs to use
and executes valve opening and closing to create pulse patterns that reﬂect the programmed
proﬁle.
???????
???? ??? ? ??? ? ??? ? ??? ? ????
???????
Figure 4.3. Timing of valve switching.
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Figure 4.4. Determining optimal PWM conditions. (a) Schematic of experimental conditions
tested and programmed concentration proﬁle. (b) Experimental results. Images were acquired
every 5 s at the end of the serpentine channels and analyzed for ﬂuorescence intensity. Right-
ward shift of the data compared to the expected proﬁle is caused by the time required for the
solutions to travel from the PWM area to the end of the channel. Yellow boxes indicate optimal
conditions.
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4.3.2 Optimizing PWM total cycle length
To determine the optimal operating conditions for the PWM chip, we conducted experiments
with 2 inputs. Since we aimed to engineer a chip that would be functional for low and high
molecular weight proteins in addition to small molecules, we tested 10 kDa FITC-dextran,
150 kDa FITC-dextran, and 559 Da sulforhodamine as substrates (Fig. 4.4a). 9 different duty
cycles were consecutively implemented on chip using total cycle times of 0.5, 1, 2, and 4 s
(Fig. 4.4a). Both the short and long serpentine channels were tested, with ﬂow rates of 24 μL/h
and 19 μL/h, respectively. The ﬂuorescence intensity of the ﬂuid was measured at the end of
the mixing channels and analyzed.
We observed repeated and random experimental failures when using a 0.5 s cycling time
(Fig. 4.5). This result could possibly arise from the inability of the automated setup (a LabVIEW-
controlled relay board and solenoid valves) to perform accurately over extended periods of
timewith such high switching rates. Alternatively, the 30ms valve opening/closing timemay be
non-negligible in comparison to the short pulse lengths. All other cycle times (1-4 s) yielded an
excellent linear correlation between programmed duty cycle and mean ﬂuorescence intensity
for both the short and long serpentine and for all 3 ﬂuorescent substances (Fig. 4.4b). The
concentrations produced on chip (Fig. 4.4b) closely match the programmed proﬁle (Fig. 4.4a).
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Figure 4.5. Plot of ﬂuorescence intensity over time for a 0.5 s total cycle time. Experiment was
performed as in Figure 4.4b.
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Figure 4.6. Different cycles times on the PWM chip: Mean ﬂuorescence intensity as a function
of programmed duty cycle, derived from the data presented in Fig. 4.4b. Errors bars represent
standard deviation. Means were calculated from ~15-20 RFU measurements each and did not
include the data points that fell between two concentrations (during ramp up).
In addition to establishing that concentration can be precisely regulated, we tested conditions
that gave rise to the most homogeneous solutions. In cases of insufﬁcient diffusion, the pulses
generated at the inlet are not completely mixed by the time they reach the measurement
area. These pulses manifest as spikes of alternating high and low intensity on the raw data
64
4.3. Results
graphs (Fig. 4.4b) and equate to sizeable standard deviations on the extrapolated duty cycle
graphs (Fig. 4.6). Mixing is presumably more restricted for larger substrates, shorter mixing
channels, or longer pulses created by longer cycle times. We observed these trends in our data;
distinct pulses were especially perceptible for the 10 and 150 kDa dextrans ﬂowed through the
short serpentine at increased (2-4 s) cycle lengths (Fig. 4.4b). By testing this matrix of various
operating conditions, we identiﬁed the combinations of molecule size, mixing channel, and
cycle length for optimal performance.
4.3.3 Characterizing response time
We next conducted experiments to determine the response time of our PWM module, deﬁned
as the amount of time needed to switch from 10 to 90% of the maximum concentration. We
used a ﬂow rate of 36 μL/h for the short mixing channel and 30 μL/h for the long channel.
When performing PWM with a 1 s total cycle time, we obtained response times as low as 5
s (Fig. 4.7a,b). Depending on which substance was used, response times for the long mix-
ing channel were 2.3-3x greater than those of the short channel. Descending from 90 to
10% concentration required slightly more time than rising from 10 to 90%. As anticipated,
response time increased as substrate molecular weight decreased; for large diffusion coefﬁ-
cients, steep ramps became spread out due to extensive diffusion (Fig. 4.7a). Accordingly, the
short serpentine is better suited for experiments that call for sudden and extreme changes of
diffusion-sensitive small molecules. However as shown in Figures 4.4b and 4.6, the longer
serpentine can be successfully used for larger molecules and to create proﬁles that entail more
gradual changes.
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Figure 4.7. Response times required to switch between 10 and 90% of the maximum concen-
tration. (a) Plots showing the time needed to ramp up and down. (b) Summary of results.
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4.3.4 Testing different ﬂow rates on the PWM module
The data presented in Figures 4.4, 4.6, and 4.7 attests to the precision and quick response
time of our chip when operated with typical ﬂow rates. For these experiments, we used ﬂow
rates of ~24-36 μL/h for the short channel and ~19-30 μL/h for the long channel, generated by
pressurizing the ﬂow inputs with 4 or 10 psi, respectively. These pressures are within
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Figure 4.8. Different ﬂow rates on the PWM chip: Measured ﬂuorescence intensity result-
ing from step-wise duty cycle increases over time. Images were acquired at the end of the
serpentine channels every 5 s and analyzed for ﬂuorescence intensity.
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the standard range used for microﬂuidic chips of similar dimensions123,124. To ensure the
compatibility of our chip with a greater variety of applications, we also tested the chip with
faster and slower ﬂow velocities.
Slow ﬂow rates (11-16 μL/h) worked best when the short mixing channel was used with a
total cycle length of 1-2 s (Fig. 4.8, 4.9). Using a long mixing channel with a slow ﬂow rate
bears the risk that the ﬂuid will spend too much time in the channel. Subsequently, extensive
diffusion will obscure the programmed concentration steps. We mitigated this effect in the
long channel by extending the total cycle time to 4 s in order to create large pulses that would
homogenize more slowly. This strategy would work best for small (~10 kDa) proteins; the 150
kDa FITC-dextran pulses did not completely combine, and the sulforhodamine concentration
steps were blended as a consequence of diffusion (Fig. 4.8, 4.9).
When coupling faster ﬂow rates (49 μL/h)with the shortmixing channel, pulses passed through
the channel too quickly and exited still intact. Only the long channel promoted complete
?????????????? ??????????????????? ????????????????????
??
??
????
??
??
??
??
???
???
??
??
??
???????????????
??????????
???????
???????????????
??????????
???????
????????????????
?????????
???????
????????????????
?????????
???????
Figure 4.9. Different ﬂow rates on the PWM chip: Mean ﬂuorescence as a function of pro-
grammed duty cycle, derived from the data presented in Figure 4.8. Errors bars represent
standard deviation. Means were calculated from ~15-20 RFU measurements each and did not
include the data points that fell between two concentrations (during ramping up).
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Figure 4.10. PWM dynamic range and control of on chip concentration. Experimental result
superimposed with programmed values for 10 kDa FITC-dextran. Images were acquired at
the end of the long serpentine channel every 10 s, analyzed for ﬂuorescence intensity, and
converted to absolute concentration using calibration images.
diffusion for fast ﬂow rates owing to the increased passage time (Fig. 4.8, 4.9). Additionally,
we applied the shortest possible total cycle time (1 s) to generate short pulses that would
homogenize faster and expedite the mixing process. Comparing the fast ﬂow data to the slow
ﬂow data reveals that our chip can support more than a 4-fold change in ﬂow rates. These ﬂow
rates (11-49 μL/h) are compatible with those used for low to medium throughput microﬂuidic
studies of bacteria125,126 and mammalian cells103,127,128. The faster ﬂow rates necessary for
high-throughput culturing devices129 could be achieved by scaling up the features of the PWM
chip, which would decrease ﬂuidic resistance.
4.3.5 Characterizing the dynamic range
For all experiments we used a minimum duty cycle of 0.1 and maximum of 0.9 to ensure that
the valve opening and closing times (30 ms, Fig. 4.3) were not too substantial compared to
pulse lengths. Cycle times greater than those tested in this work equate to longer pulsing
lengths and can most likely support more extreme duty cycles. In order to broaden the
dynamic range of output concentrations while keeping duty cycles between 0.1 and 0.9, we
connected the chip to multiple preparations of the same substance at different concentrations.
A series of 9-fold dilutions was performed to prepare 3 stock solutions of 10 kDa FITC-dextran.
Our automated platform selects which stock solution to use based on the desired output
concentration.
We performed this experiment using standard PWM conditions (1 s cycle length, long serpen-
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tine channel, and a 27 μL/h ﬂow rate). The chip was programmed to create concentrations
that fell within low (0.15–1.35 μM), medium (>1.35–12.15 μM), and high (>12.15–109.35 μM)
ranges. The difference between the maximum (109.35 μM) and minimum (0.15 μM) concen-
tration values is ~3 orders of magnitude, or a 729-fold change. We also acquired reference
images of each stock solution, allowing us to convert ﬂuorescence intensities at the outlet of
the mixing channel to absolute concentrations. We found that the generated concentration
proﬁles closely matched the programmed values for all 3 inlet pairs (Fig. 4.10). Diffusion of
FITC-dextran in the serpentine channel converts the step-wise proﬁle of the input ﬁle into a
smooth contour.
Due to the limited sensitivity of ﬂuorescence detection on our setup, we tested only 3 serial
dilutions. The 729-fold concentration range presented in Figure 4.10 is for example well
within the typical difference between the minimum and maximum serum concentration of
antibiotics measured in clinical studies130,131. However if all 6 inlets of the chip were to be
utilized (5 stock solutions prepared as 9-fold serial dilutions and 1 buffer), a 59049-fold range
of output concentrations could be produced. These results suggest that our technology can
accurately replicate complex in vivo concentration proﬁles.
4.3.6 Connecting the PWM module to a second chip
The PWM module can be easily integrated into chips fabricated by multilayer soft lithogra-
phy132 due to its small size and the standard dimensions of its channels. To extend the use of
the PWM module, we tested whether the PWM module could be connected to a second chip,
bypassing the need to re-fabricate existing chips and allowing the PWM module to work with
a wide variety of microﬂuidic devices fabricated with different techniques and materials. We
constructed this setup by using ﬂexible PEEK tubing to join the outlet of the short, straight
channel (Fig. 4.2a) of the PWM module to the inlet of a second chip. The PEEK tubing has a
50.8 μm inner-diameter, equating to a ~1.5x larger cross-section than the microﬂuidic mixing
channels. Faster ﬂow rates were required to prevent excessive diffusion and delayed response
times. The geometry of the PEEK tubing also leads to lower ﬂuidic resistance compared to the
microﬂuidic channels, allowing one to obtain higher ﬂow rates with less pressure.
We successfully produced programmed concentration proﬁles in the second chip when using
10 cm of connective PEEK tubing, a medium ﬂow velocity (47 μL/h), and a 4 s total cycle length
(Fig. 4.11a,b). A faster ﬂow rate of 80 μL/h was achieved when the cycle was shortened to 2 s
(Fig. 4.11a,b). Compared to the minimum ﬂow rate of 11 μL/h we previously demonstrated
(Fig. 4.8), this signiﬁes that a 7.3-fold range of ﬂow rates can be used with our platform. The
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Figure 4.11. PWM chip used upstream of a second device. (a) Measured ﬂuorescence intensity
resulting from step-wise duty cycle increases over time. Images were acquired near the inlet
of the second chip every 5 s. (b) Mean ﬂuorescence intensity as a function of programmed
duty cycle. Error bars represent standard deviations. Means were calculated from 10-15
RFU measurements and did not include the data points that fell between two concentrations
(during ramping up).
ability to support higher ﬂow rates ensures that our PWM module can be used in conjunction
with more high-throughput applications such as microﬂuidic chemostats90,133,134. The 2-chip
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setup can likely be used with an even greater range of ﬂow rates so long as the total cycle time
is adjusted accordingly to provide control over diffusional mixing.
4.3.7 Complex, long-term and PK/PD concentration proﬁles
Complex concentration proﬁles can also be implemented when a PWM module is connected
upstream of a second chip. Using a ﬂow rate of 47 μL/h, a 4 s cycling time, and 6 cm of
PEEK tubing to connect the two chips, we simultaneously changed the concentrations of
two substances, generating sine curves of changing periods for sulforhodamine and 10 kDa
FITC-dextran (Fig. 4.12a). The 4 s cycle consisted of 3 components: a sulforhodamine pulse, a
FITC pulse, and a buffer pulse (Fig. 4.12a). Sulforhodamine and FITC could each be pulsed for
a maximum of 2 s, and pulse on/off times were selected independently for each substance.
The off times for both sulforhodamine and FITC were combined into one buffer pulse. This
technique allowed us to create sine curves with periods of 5, 10, 20, 30, and 45 min for
FITC, and 80 and 60 min for sulforhodamine (Fig. 4.12a). Our LabVIEW interface enables
the user to run custom concentration proﬁles encoded in text ﬁles and is not limited to
simple mathematical functions. The ability to independently control the concentration of
several substances at once on chip is pertinent to complex biological studies that require the
simultaneous delivery of multiple factors as commonly required in stem cell differentiation or
reprogramming experiments135.
We have shown that our device can implement fast concentration changes and programs
lasting up to 2 h (Fig. 4.7, 4.12a). These parameters are compatible with chemical and in
vitro studies. However, biological studies and especially those involving cell cultures call for
extended experimental periods. We thus evaluated the capacity of our device to manipulate
and sustain concentrations on time scales spanning up to 48 hours. Using the long serpentine
channel, a ﬂow rate of ~30 μL/h, and a 4 s cycling time, we performed PWM with sulforho-
damine and 10 kDa FITC-dextran in parallel. Each substance was either stably maintained
at 0.1 (10% of maximum) or gradually ramped up to, or down from, 0.9x (90% of maximum)
(Fig. 4.12b). Each peak spanned 2, 4, 6, or 8 h, which are time ranges relevant for drug dosage
and pharmacokinetic studies130,131. We found that for all ramping times, the desired proﬁle
was accurately generated (Fig. 4.12b). The 48 h experiment was not subject to errors or chip
failure, showing the robustness of our setup.
The ability to slowly ramp concentrations over long periods of time would be relevant for
on chip pharmacokinetic and pharmacodynamics (PK/PD) studies. To demonstrate the
utility of our device for this application, we mimicked the 12 h concentration time-proﬁles
in plasma for orally administered drugs136 (Fig. 4.12c). Chip operating conditions were the
same as those employed in Fig. 4.12b, and sulforhodamine and FITC were programmed
simultaneously. Both molecules started at 0 concentration and quickly increased to 0.9 (90%
intensity), corresponding to release of the drug from the formulation and absorption into the
bloodstream79,137. After reaching maximum concentration, both substances decrease
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Figure 4.12. Complex experiments on the PWM chip. (a) PWM of sulforhodamine and 10
kDa FITC-dextran in parallel, programmed as sine curve functions with changing periods.
Images were acquired near the inlet of the second chip every 10 s, analyzed for ﬂuorescence
intensity, and converted to absolute concentration using calibration images. (b) PWM of
sulforhodamine and 10 kDa FITC-dextran in parallel, gradually ramped to create peaks of 2, 4,
6, or 8 h duration. Images were acquired at the end of the long serpentine channel every 2 min
for 48 h, analyzed for ﬂuorescence intensity, and normalized from 0 to 1 based on minimum
and maximum ﬂuorescence intensity. (c) Simultaneous generation of two different PK proﬁles
using sulforhodamine and 10 kDa FITC-dextran. Images were acquired and analyzed as in (b).
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Figure 4.13. Guide to selecting chip operating conditions for different experimental setups.
Blue, optimal; red, non-optimal.
gradually (to a ﬁnal value of 0.1 for sulforhodamine and 0.29 for FITC), representingmetabolism
and elimination of the drug. The experimental results closely match the programmed values
in both shape and concentration (Fig. 4.12c). These proﬁles can be custom-generated on chip
to reﬂect different drugs, delivery methods, and formulations. This feature would be especially
advantageous for studies investigating the interactions of multiple drugs to identify synergy
or antagonism. When used in this manner, our PWM module could be connected upstream
of existing devices to facilitate PK/PD and other dosage-dependent studies. Compared to
previously developed PWM microﬂuidic chips85–87,122, our module enables more complex
studies to be performed (Table 4.1). We have shown that our chip can be used in a variety of
conﬁgurations, and a guide to selecting the optimal conditions for each desired ﬂow rate and
experiment type is presented in Figure 4.13.
4.4 Discussion
Our PWM module demonstrates several improvements over current microﬂuidic dilution
methods (Table 4.1). Compared to previous chips, our platform enables long-term experi-
ments, manipulates the concentration of multiple substances in parallel, and works with a
variety of molecule sizes and ﬂow rates. Moreover, the PWM module can easily be connected
upstream of a second device. We have thoroughly characterized the platform to aid the user in
selecting the optimal conditions for a given experiment (Fig. 4.13). The PWM module itself is
easy to fabricate using standard multilayer soft lithography and the design ﬁles are available
for download (lbnc.epﬂ.ch).
Microﬂuidics is increasingly being used as a tool to model in vivo conditions due to reduced
sample requirements, regulation of the microenvironment, and compatibility with single-
cell analysis. However, typical devices lack the ability to gradually ramp concentrations on
chip and instead simply perform non-physiological step-functions by switching between on
and off states for a given substance in the culturing medium. We address this limitation by
allowing the user to generate arbitrary concentration-time proﬁles of several substances with
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Table 4.1. Comparison of the PWM module presented in this work to previous microﬂuidic
applications of PWM.
complete control over both timing and concentration. The device can be programmed to
generate PK/PD proﬁles, a feature that is especially relevant in light of recent developments
in organ-on-chip and microﬂuidic stem cell technologies138,139. Overall, our PWM platform
complements existing biomedical microﬂuidic devices and will facilitate studies that better
reﬂect the in vivo environment by emulating physiologically relevant temporal changes in
concentrations.
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4.5 Experimental
4.5.1 Chemicals
Sulforhodamine, FITC-dextran 10 kDa, and FITC-CM-dextran 150 kDa were purchased from
Sigma Aldrich.
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4.5.2 Automated pneumatic setup
Actuation of microﬂuidic valves was controlled by a setup consisting of a 16 channel USB relay
module (Numato lab) connected to 24V solenoid pneumatic valves arranged on manifold
(Pneumadyne). A custom written LabVIEW VI was used to control the opening and closing
of the valves on the chip (see Appendix). To run the program, the user supplies a text ﬁle
containing a list of desired concentrations over time. The LabVIEW program selects which
ﬂow inputs to use, then calculates and executes the pulsing times of each input required to
achieve the desired concentration. The total cycle length can be adjusted in the program.
4.5.3 Imaging
Imaging of the microﬂuidic chip was performed on a Nikon Ti-E Eclipse automated micro-
scope using NIS Elements. 16-bit TIFF images were acquired with an Ixon DU-888 camera
(Andor Technology), using 20x magniﬁcation to capture the last ~700 μm of the mixing channel
in the ﬁeld of view. For imaging ﬂuorescence, two HC ﬁlter cubes were used: TexasRed (HC
562/40, HC 624/40, BS 593) for sulforhodamine and FITC (HC 482/35, HC 536/40, BS 506) for
FITC-dextran (all ﬁlters from AHF Analysentechnik AG). Images were analyzed using a custom
written Matlab script in which a box of 100 μm length and including the entire width of the
channel was selected and analyzed for mean intensity (see Appendix). High-speed imaging of
valve closure was performed using a FasTec Imaging HiSpec 2G camera and FasTec imaging
software.
4.5.4 Microﬂuidic device fabrication
Microﬂuidic chips were fabricated as previously described140. Devices were designed in
Clewin (WieWeb software, Netherlands). Two molds were designed: one for the control
layer, which contains the valves, and another for the ﬂow layer, which contains the channels
and chambers necessary for reagent introduction and cell culturing. The control layer was
scaled by 101.5% to account for PDMS shrinkage during curing. The molds were fabricated
using standard photolithography methods. The control layer mold was patterned with SU-
8 photoresist (Gersteltec, Switzerland) to a height of 30 μm, then exposed and developed.
The channels on the ﬂow layer were generated by spin coating AZ9260 to a height of 14 μm,
followed by exposure and development. The AZ9260 was annealed at 120 ◦C for 10 min to
produce the rounded proﬁle that is required for complete valve closure. Polydimethylsiloxane
(PDMS; Sylgard 184, Dow Corning Corp., USA) was cast onto the molds and multilayer soft
lithography techniques were used to assemble the chip. A thick layer of PDMS (5:1 ratio of
parts A:B) was poured onto the control layer, whereas the ﬂow layer was spin coated with
PDMS (20:1 ratio of parts A:B) with a ramp of 15 s and a spin of 35 s at 3000 rpm. The molds
were baked for 30 min at 80 ◦C. The control layer chips were then cut, removed from the mold,
and punched with inlet holes. The control layer chips were aligned to the ﬂow layer, and the
assembly was baked for 90 min at 80 ◦C. The aligned devices were then cut, removed from the
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mold, and punched with inlet and outlet holes. The chips were placed on top of a glass slide
that had been coated with 20:1 PDMS (15s ramp time and 35s spin at 1500 rpm) and baked for
30 min at 80 ◦C. Finally, the entire assembly was placed under a weight and bonded overnight
at 80 ◦C.
4.5.5 Microﬂuidic chip operation
The pressures of the ﬂow and control layers of the chip were controlled by using a custom
built pneumatic setup. The valves of the control layer were ﬁrst primed with ﬁltered water at
5 psi. Once all air had been removed from the control lines, the control layer pressure was
increased to 25 psi. The ﬂow layer of the chip was washed with water before each experiment.
Flow rate was determined by measuring the volume of liquid exiting the chip over a period of
time. Tygon tubing was used for most ﬂuidic connections. For experiments in which a PWM
device was attached to a second device, 50.8 μm diameter PEEK tubing (VWR) was used. One
end of a 6-10 cm piece of the tubing was inserted directly into the outlet hole of the PWM chip
and the other end was placed into the inlet of the second chip.
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5.1 Summary of Results
Microﬂuidics is increasingly being used as a tool for cell-based assays due to reduced sample
requirements, higher throughput, advanced control over the microenvironment, and compat-
ibility with single-cell analysis. In this work we developed accessible microtechnologies that
enable complex, high-throughput experiments with mammalian cells. These platforms are
modular and can be combined with existing technologies and assays.
In Chapter 2, we described a novel method to arrange cells into high-density nanowells (live
mammalian cell arrays, or LMCAs) for culturing and high-content analysis. The well array
can either be purchased or constructed using basic microfabrication protocols. Deposition of
the cells into the nanowells requires a microarray printer, which is a standard machine used
by many laboratories to generate DNA and protein arrays. Up to 675 different cell lines can
be cultured with low cross-contamination on a single microscope slide; the well density on
the LMCAs is ~2.6 times greater than that of a 1,536-well plate. A variety of cell lines were
arrayed at high viability with no detectable change in phenotype, even for sensitive cell types.
For example, hMSCs (human bone marrow-derived mesenchymal stem cells) retain their
adipogenic differentiation potential when cultured in the nanowells for 10 days in appropriate
medium. We have furthermore reﬁned our technique to provide control over cell seeding
density, for compatibility with a variety of cell types, and integration with transfection.
Similar to the LMCAs described in Chapter 2, Chapter 3 presents another high-throughput
tool for mammalian cell biology. We created a microﬂuidic chip that is the size of a standard
microscope slide and cultures mammalian cells and simultaneously performs 280 indepen-
dent transfections at up to 99% efﬁciency. Our technology bears advantages over the original
reverse transfection method, in which a glass slide spotted with an array of transfection mix-
tures is seeded with cells33. On our chip the culturing environment is tightly regulated and
chambers physically separate the transfection reactions, preventing cross-contamination. Co-
transfection can also be achieved, with the expression ratio of co-transfected proteins precisely
controlled by adjusting the composition of the transfection mixture. This principle allowed
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us to perform synthetic biology experiments on the chip; in Chapter 3, we co-transfected 4
plasmids to express a two-component signaling pathway (developed by Hansen et al.114). Our
platform is easily adapted to high-content imaging and cells can be continuously monitored
during culturing, permitting the monitoring of temporal responses. With our platform, we
can collect signiﬁcantly more data than the end-point methods (e.g. FACS) that are typically
used for mammalian synthetic biology.
In addition to the techniques presented in Chapters 2 and 3, there is a plethora of microﬂuidic
devices that have been recently developed for mammalian cell studies141,142. However, typical
devices lack the ability to gradually ramp concentrations on chip and instead perform step
function changes, switching between on and off states for a given substance in the culturing
medium. This setup poorly reﬂects the in vivo environment, in which concentrations of
molecules follow a complex, continuous rise and fall pattern. In Chapter 4, we addressed
this limitation by creating a device that uses pulse-width modulation (PWM) to automatically
generate arbitrary concentration values by mixing 2-6 input solutions. The PWM device can
produce complex, dynamic concentration proﬁles over timescales of up to 48 h and with a
dynamic range of 3-5 orders of magnitude. Proﬁles for two molecules can be programmed
simultaneously, with each concentration independently controllable. The device is versatile
and functions with a large variety of molecule sizes and ﬂow rates. The PWM module may
moreover be connected upstream of another device, avoiding the need to re-fabricate existing
chip designs.
5.2 Limitations
Culturing of the LMCAs presented in Chapter 2 involves immersing the entire array into
medium, therefore this method is not suitable for non-adherent cell types. This culturing
approach may also contribute to molecular cross-contamination. For example, cells contained
within one well may secrete proteins that are received by and inﬂuence the behavior of an
adjacent well containing a different type of cell. Increasing the total volume of the culturing
medium may successfully dilute secreted molecules to negligible levels. However, this strat-
egy might inhibit essential paracrine interactions that require high local concentrations of
signaling molecules.
All wells on the LMCAs are cultured in the same type of medium, precluding control over
culturing conditions for individual samples on the array. Customization of each well may be
achieved by patterning the culturing surface with speciﬁc molecules prior to cell deposition.
Surface chemistry techniques can potentially be employed to generate stable modiﬁcations
such as ECM-like matrices. However, soluble and non-adhered molecules will be washed out
of the wells when the array is submerged in medium for long-term culturing. Liquid-handling
robotics is better suited for generating complex matrices of cell types and culturing conditions,
although this equipment is more expensive and not as commonly used as the standard contact
spotting approach presented herein.
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5.2. Limitations
Aside from its utility in novel applications such as LMCAs, contact spotting has contributed
to the adaptation of routine laboratory processes to high-throughput formats (for example,
reverse transfection33). The approach presented in Chapter 3 is based on reverse transfection
and relies on contact spotting to deposit chemical transfection mixtures into cell culturing
spaces. The lipid reagent can also be ﬂowed into the entire chip after spotting is completed,
obviating the need to add the reagent individually to each transfection mixture. However, for
co-transfections plasmids must still be manually mixed, impeding synthetic biology exper-
iments that involve complex plasmid mixtures. One possible solution would be to create a
stock solution of each plasmid and perform multiple rounds of spotting to “mix” the stocks on
the array, but this strategy yielded unreliable results (see Appendix).
Our microﬂuidic platform performs transfection at high efﬁciency, but the chemical-based
method relies upon actively dividing cells. Electroporation may be more appropriate to study
a greater variety of cell types, since delivery of genetic material is not dependent on mitosis
(See Chapter 1 and Table 1.1). Another drawback of our system is that protein expression
is transient and limited to a few days. For observing long-term cellular processes, stable
protein expression induced by viral transduction would be desirable. Although arrays of
lentiviruses have been created47 and in principle could be integrated with microﬂuidics,
individual preparation of the viruses and their concentration for printing is tedious and
requires a dedicated BSL-2 working space. Ideally, lentivirus components would be produced
and assembled on chip by a group of producer cells and used to transduce a group of target
cells on the same chip. We attempted this approach with limited success (see Appendix),
indicating that many parameters remain to be optimized.
Likewise, modiﬁcations to our PWM device would expand its utility for a larger range of appli-
cations. In Chapter 4, we demonstrated how the PWM device could be used to simultaneously
manipulate two molecules of interest. The ability to program 3 or more substances in parallel
is pertinent to complex biological processes such as stem cell reprogramming and differentia-
tion. We found that performing PWM with 3 or more substances may require re-optimization
of total cycle times, pulse programming methods, and possibly device dimensions. Pulsing
multiple molecules in parallel increases the total cycle time, which is the sum of pulse on and
off times for each substance. Pulse on/off times cannot simply be scaled down to decrease
total cycle time, since these intervals must be sufﬁciently long to avoid infringing upon min-
imal valve opening/closing times. This increase in cycle time will likely necessitate longer
mixing channels to promote full diffusion of the pulses (alternatively, the 2-chip setup and
adjustments in the length of mixing tubing may be explored). The mixing of molecules with
drastically large size differences (and thus different diffusion properties) may also require
careful optimization.
Although we used standard pressures123,124 to drive the ﬂow on our PWM device, the resulting
ﬂow rates (11-80 μL/h) are signiﬁcantly lower than those employed by high-throughput and
cell culturing applications such as chemostats90,129,133,134. Increasing the pressure can to
some extent accelerate the ﬂow, but often results in mechanical deformations in the valve
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pulsing area (causing inaccurate dispensing of pulses) or device delamination and failure. A
more suitable option would be to scale up the dimensions of the microﬂuidic components,
promoting higher ﬂow rates by decreasing ﬂuidic resistance. For example, the PEEK tubing
that we used for the 2-chip setup has a cross section area that is ~1.5x larger than that of
the microﬂuidic mixing channels and allowed us to easily generate a ﬂow rate of 80 μL/h,
compared to the ~20-36 μL/h ﬂow rates of the microﬂuidic mixing channels.
5.3 Outlook
We interrogated the LMCAs introduced in Chapter 2 by microscopy, observing both cell
morphology and ﬂuorescently labeled structures of interest. Additional information may
be obtained by coupling the LMCAs with microengraving. In this approach, cell arrays are
sealed against a functionalized glass slide143. Secreted proteins in the medium are captured
on the surface of the glass slide, creating an array of spots that corresponds to the array of cell
culture wells. The glass slide is then detached from the cell array and stained to identify and
quantify speciﬁc proteins. This assay facilitates the detection of different proteins secreted by
cells and, in the LMCA context, could streamline the screening hybridomas and libraries of
antibody-producing cell lines.
Our LMCA method is modular, and aside from microengraving it can be combined with
a number of other existing technologies. LMCAS are both high-throughput and consume
small amounts of sample, making them superior to standard microtiter plates for handling
extensive collections of rare or primary cells. LMCAs could be used to study large libraries
of cell lines, which have recently become available2,3. Alternatively, this system could be
applied to elucidate the stem cell microenvironment, which plays an important role in guiding
differentiation and organization5. Integrating artiﬁcial niche arrays6,97 with the cell-arraying
technology developed herein would enable screening of artiﬁcial cellular matrices for a vast
number of cell types. Lastly, the effect of speciﬁc intracellular proteins on cells cultured in
LMCAs may be interrogated via transfection. The optimized microﬂuidic transfection method
developed in Chapter 3 could be applied to the nanowells to increase transfection efﬁciencies.
High content screens performed with arrays cultured in the presence of a molecule of interest
would uncover fundamental cell mechanisms and assist in drug discovery and development.
Similarly, the transfection technique described in Chapter 3 can investigate the impact of
protein expression on cell responses to stimuli such as a change in the culturing medium
or introduction of a drug. Moreover, the novel design of the microﬂuidic chip allows down-
stream manipulation to be performed without any cross-talk between different transfection
chambers. For example, ﬂuidic manipulation could be used to direct the conditioned medium
produced by a chamber of transfected cells towards a group of responder cells. This setup
could measure the chemotaxis of stem cells in response to a large library secreted proteins144.
Other possibilities include using this technology to produce protein arrays and co-culture
different types of cells in the same chamber (see Appendix).
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As shown in Chapter 3, the transfection chip is applicable to synthetic biology. The automated
deposition of transfection mixtures is advantageous compared to the manual transfection of
multiwell plates typically used for synthetic biology experiments. Synthetic biology studies
necessitate the simultaneous delivery of multiple constructs at precise ratios (see Appendix for
an example of a complex synthetic system), and transfection conditions must be painstakingly
optimized before synthetic circuits can be tested. The transfection chip platform could thus
provide a solution to increasing throughput in synthetic biology. Subsequent work could
further characterize synthetic circuits by examining their response to activating or repressing
molecules introduced in the culturing medium. A microﬂuidic setup would serve to tightly
control the concentration and timing of incubation of these molecules.
When studying molecules of interest in biological experiments, a pressing concern is the
inability to generate physiological concentration curves. Standard well-plate systems rely
on changes in the culturing medium to sequentially modify the concentration of a molecule.
This process poorly represents the dynamic, continuously increasing and decreasing patterns
of proteins such as transcription factors. The PWM platform presented in Chapter 4 offers
considerably higher accuracy in mimicking biological processes, enabling experiments that
were previously unachievable due to technical limitations.
The PWM device could for instance be connected upstream of a second chip to facilitate
complex and physiologically relevant experiments with mammalian cells and bacteria. Upon
connecting the PWM chip to the transfection chip described in Chapter 3, one could study
the temporal effect of a molecule on a library of expressed proteins. The chip’s capacity to
generate pharmacokinetic/pharmacodynamic (PK/PD) proﬁles furthermore provides accu-
rate simulations of drug concentrations in vivo. This feature could be used in combination
with microﬂuidic chemostats90,133,134 to elucidate mechanisms of antibiotic resistance and
persistence in bacteria145. The ability to program multiple substances in parallel would shed
light on the interactions of multiple drugs and help identify synergy or antagonism. The
simultaneous, temporally controlled delivery of several molecules may also be applied to
microﬂuidic experiments involving stem cell differentiation and reprogramming135.
In summary, in this work we have created microﬂuidic tools for high-throughput screening,
mammalian cell engineering, and physiologically relevant studies on chip. These modular
platforms can be integrated with recent developments in mammalian synthetic biology, organ-
on-chip, and microﬂuidic stem cell technologies. Taken together, the developments presented
in this thesis promise to increase throughput and better replicate the in vivo environment for
cell-based assays and drug discovery.
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6.1 Co-spotting method for co-transfection
In Chapter 3, co-transfection was performed by preparing a separate lipid-DNA mixture
for each desired expression ratio. We also tested a co-spotting technique, in which one
transfection mixture was prepared for each plasmid and spots on the array were stamped
multiple times. The number of times each plasmid was stamped determined its ratio in the
ﬁnal transfection mixture. Co-transfection efﬁciency was extremely low for this technique (Fig.
6.1), perhaps due to the fact that each plasmid is incorporated into a different transfection
reagent micelle; the micelles might be taken up differently by the cells based on the order in
which theywere spotted. For a standard transfection, plasmid size is ~22 by 50 nm, transfection
reagent micelles are 200-800 nm in diameter, and 75-50,000 plasmids ultimately end up in the
nucleus146,147. For the co-spotting method, protein expression ratios also did not correspond
to the spotted DNA ratios. Multiple attempts were made to optimize the method including
diluting the transfection mixtures before spotting, changing the arraying parameters and pin
size, modifying the order in which each mixture was spotted, and by spotting only gelatin-DNA
and ﬂowing in the transfection reagent on chip.
6.2 Lentivirus transduction on chip
In addition to chemical transfection, we attempted viral-mediated transduction for stable
protein expression. HEK cells were cultured on chip and simultaneously transfected with
3 lentiviral plasmids (transfer, packaging, and envelope) with the objective of instigating
lentivirus production and subsequent self-infection. After a few days of culture on the chip,
cells were removed and cultured in well plates to evaluate long-term protein expression. Some
colonies of cells were observed with stable protein expression (GFP, encoded on the transfer
plasmid) after 14 days (Fig. 6.2). This result was most likely due to expansion of a few cells
that underwent the random genomic integration that can occur with transient transfection (1
per 10,000-1,000,000 cells). Performing the same experiment without one of the essential
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Figure 6.1. Co-transfection performed by co-spotting or pre-mixing transfection mixtures
containing tdTomato and eGFP. The Tom:GFP DNA ratio was 1:1. The pre-mixed transfec-
tion approach results in more co-transfected (yellow) cells compared to the total number of
transfected cells.
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Figure 6.2. Generation of cell colonies stably expressing GFP 14 days after transfection on
chip. Cells were transfected on the standard transfection chip (Chapter 3). Images: cells were
either transfected with all 3 lentivirus plasmids (GFP-transfer, packaging, and envelope), or
only 2 of the 3 essential plasmids (GFP-transfer and packaging). GFP expression was evaluated
by ﬂuorescence imaging.
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Figure 6.3. Chip design for a sender-receiver cell system. HEK cells are transfected with
the 3 lentivirus plasmids overnight with the objective of releasing functional lentivirus into
the medium. The outlet of the sender (HEK) chip segment can be connected to the inlet
of the receiver (Tom FB) chip segment via ﬂexible tubing to incubate the receiver cells with
lentivirus-containing medium.
lentiviral plasmids resulted in approximately the same number of stably transfected cell
colonies, indicating that the cells failed to produce functional lentivirus.
A co-culture system was also designed, in which the conditioned medium from lentivirus-
producing cells was introduced to a second group of cells cultured on a separate segment
of the chip. For example, in one setup we used HEK cells as virus producers and Tomato-
expressing ﬁbroblasts as receivers (Fig. 6.3). Failure of the sender-receiver experiments could
be attributed to slow lentivirus diffusion into chambers (>30 min, compared to 10 min for
small proteins present in serum, Fig. 6.4) or insufﬁcient viral titer. Strategies to increase
transduction efﬁciency, such as growing sender cells in the same chamber as receiver cells
and the addition of polybrene, ﬁbronectin, or poly-l-lysine were attempted without success.
6.3 Co-culture on the transfection chip
Two different cell types can be cultured in the same microﬂuidic chamber to facilitate the study
of paracrine interactions. The sieve design of our transfection chip (Chapter 3) is well suited
for studying non-adherent or rare responder cells. High local concentrations of chemokines
can be created owing to the small volume contained in the microﬂuidic culturing chambers,
and transfection of producer cells obviates the need to purchase costly puriﬁed proteins. For
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Figure 6.4. COMSOL modeling of lentivirus diffusion. A model was constructed to measure
the time required for molecules in the feeding channel to fully diffuse into the center of the
chambers during continuous ﬂow. HIV was used to represent a lentiviral particle148.
Figure 6.5. Co-culture of HEK (GFP-expressing) and Jurkat cells on the transfection chip. Left:
a culturing chamber containing a ~1:1 ratio of HEK and Jurkat cells, imaged 5 h after loading
onto the chip. Right: at low cell culturing densities, the Jurkat cells tend to cluster around the
HEK cells, which may possibly serve as feeder cells (imaged 20 h after loading).
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example, we used our platform to co-culture HEK cells and Jurkat T lymphocytes (Fig. 6.5).
Immunostaining could be used to decipher which pathways are activated when the Jurkat
cells are exposed to proteins produced by transfected HEK cells. Both validated chemokines
(such as IFN-alpha, CCL5, CCL3, IL-6, PDGF, and EGF) and libraries of secreted proteins could
potentially be screened.
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Figure 6.6. 96-well plate transfection of a CRISPR transcriptional repression device. (a) Trans-
fection controls of ﬂuorescent proteins. (b) Schematic of the repressive system. (c) eYFP is not
expressed when Gal4VP16 is not expressed. (d) eYFP is expressed when Gal4VP16 is expressed.
(e) eYFP is not repressed when only one component (Cas9) of the repressing mechanism is
present. (f) eYFP is not repressed when only one component (gRNA) of the repressing mecha-
nism is present. (g) eYFP expression is repressed (signiﬁed by lower ﬂuorescence intensity)
when both elements of repressive system (Cas9 and gRNA) are present. Merged images are
shown on the left, and mKate and eYFP channels are shown separately on the right. mKate
serves as a transfection control. We thank Samira Kiani and Ron Weiss for providing the
plasmids.
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6.4 Co-transfection of a complex synthetic system
Complex genetic circuits have been recently developed for mammalian cells, such as the
modular CRISPR-Cas9 transcriptional repression system developed by Kiani et al44. Up
to 5 plasmids must be co-expressed: an mKate transfection control, eYFP, Gal4VP16 for
eYFP induction, and Cas9 and gRNA for eYFP repression (Fig. 6.6). The tedious process of
determining ideal co-transfection ratios could be mitigated by using an automated platform
such as the one presented in Chapter 3 for screening.
6.5 Producing protein arrays using the transfection chip
Proteins expressed in mammalian cells, opposed to those expressed in vitro or in prokaryotic
systems, are properly folded and post-translationally modiﬁed. Protein arrays are fabricated by
printing puriﬁed samples16,34,35, which is both time-consuming and costly. As an alternative,
the reverse transfection chip that we presented in Chapter 3 could be processed to yield a
protein array-like product. Speciﬁcally, the cells grown in the chambers, each expressing a
unique epitope-tagged protein, would be lysed. Proteins released from each chamber can
be speciﬁcally pulled down by using common surface patterning protocols, such as those
administered for MITOMI-based devices149,150.
We created both a chip that resembled the device introduced in Chapter 3 (Fig. 6.7) and a user-
friendly chip that supports pipet and vacuum loading of cell samples (Fig. 6.8). These chips
could be used to test protein-protein interactions and characterize antibody-producing cell
lines. A microﬂuidic button mechanically crushes and lyses cells, and released proteins diffuse
to a separate chamber for analysis. Captured proteins can be tested for their interactions with
a second protein, which is ﬂowed perpendicular to the direction of cell sample loading. We
demonstrated the operation of this device by loading it with GFP-expressing HEK cells (Fig.
6.9). To capture GFP exclusively in the button region, we arrayed BSA-biotin on a glass slide,
aligning the array to a chip and ﬂowing in neutravidin with protein capture buttons open.
BSA-biotin was ﬂowed next, with buttons closed to inactivate the area around the button.
Buttons were opened for patterning with a biotinylated anti-GFP antibody and during capture
of GFP released from cells. Following protein capture, buttons were closed for a ﬁnal wash.
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Figure 6.7. Microﬂuidic chip for protein pull-down from transfected cells. Full chip (upper)
and close-up (lower). Cells can be transfected in the cell chambers, and expressed intracellular
proteins are released when the button is activated to lyse the cells. Proteins diffuse into the
protein chamber, where they are captured on the surface.
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Figure 6.8. Microﬂuidic chip to study protein-protein interactions from cell samples. Full chip
(left) and close-up (right). Cell samples are introduced in the chip by pipetting and vacuum
loading. Protein samples can be ﬂowed perpendicular to cell samples to generate a matrix for
protein-protein interaction testing.
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Before cell crushing After cell crushing 
Cell chamber 
Protein chamber Protein chamber 
Cell chamber 
BF Fluorescence 
BF Fluorescence 
BF Fluorescence 
BF Fluorescence 
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= surface chemistry
= no surface chemistry (no BSA-biotin spotted)
WT HEK cells
GFP HEK cells
Figure 6.9. On-chip mechanical cell lysis and GFP capture. Cells are mechanically lysed by
activating the cell-crushing button. Proteins are captured only when the protein chambers are
functionalized with the correct surface chemistry.
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6.6 MATLAB codes
MATLABcodeused for analysis of co-transfectionefﬁciencies and ratiospresented inChap-
ter 3.
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MATLAB code used for the analysis of transfection efﬁciencies and protein expression lev-
els presented in Chapter 3.
94
6.6. MATLAB codes
MATLAB code used for the binned histogram analysis presented in Fig. 3.16, 3.18.
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MATLAB code used for PWM analysis.
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MATLAB code used for co-plotting PWM results.
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6.7 LabVIEW VIs
The following images show a LabVIEW VI that was used for large dynamic range PWM ex-
periments such as the one shown in Figure 4.10. This speciﬁc VI has been adapted for a 2
s cycle time and for an input text ﬁle that has values in the range of 0-729. Depending on
what concentration is desired, the VI chooses which of 3 concentrated stocks to pulse with
buffer. For desired concentrations of >0-9, the program will mix buffer (0) with the stock of
concentration 10. For desired concentrations of >9-81, stocks 0 and 90 will be mixed. For de-
sired concentrations of >81-729, stocks 0 and 810 will be mixed. Time lags caused by LabVIEW
calculations ranged from 1-6% of the total program time.
LabVIEW VI used for PWM experiments, front panel.
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LabVIEW VI used for PWM experiments, manual valve-controlling region. Shown below
is the complete block diagram (upper) and an inset of the manual valve-controlling region
(lower).
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LabVIEW VI used for PWM experiments, text ﬁle input region. Shown below is the complete
block diagram (upper) and an inset of the text ﬁle input region (lower).
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LabVIEWVIused forPWMexperiments, buffer pulsing region. Shownbelow is the complete
block diagram (upper) and an inset of the valve commands selected when a concentration of
0 is required (lower).
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LabVIEW VI used for PWM experiments, buffer and stock solution pulsing region. Shown
below is the complete block diagram (upper) and an inset of the valve commands selected
when a concentration of >0-9 is required (lower). The commands used for concentrations of
>9-81 and >81-729 are executed similarly and represent the bottom 2 case structure boxes on
the block diagram.
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LabVIEW VI used for PWM experiments, end of program region. Shown below is the com-
plete block diagram (upper) and an inset of the commands to turn all valves off at the end of
the program (lower).
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